Daniel Kelly Benjamin Jr.
Kiser-Arena Distinguished Professor
Dr. Danny Benjamin is the Principal Investigator and Chair of the National Institute of Child Health and Human Development’s Pediatric Trials Network. The Network is responsible for designing and leading clinical trials of off-patent medicines in children of all ages across all therapeutic areas. The team has established, or is actively studying, the correct dosing and safety of more than 70 of the most commonly used medicines in children. Each of these trials is conducted under an Investigational New Drug (IND) application with guidance from the Food and Drug Administration for labeling.
The Pediatric Trials Network has directly impacted the healthcare of over 90% of American children.
Signature programs of the Network include clinical trials in premature, term infants, breast feeding mothers, and obese children. Over the past 10 years, Danny’s group has enrolled more premature infants, at more sites, in more clinical trials of off-patent anti-infectives under an IND than all other academic medical centers, pharmaceutical companies, and government agencies in the world, combined.
Danny is recognized by the National Institutes of Health as a premiere mentor and educator. His research program serves as a platform to train students and early career investigators. Danny’s group has a clinical research summer program for high school and college students targeting under-represented minority students, and he is the primary mentor for medical students, residents, subspecialty fellows, and multiple junior faculty. He has been the primary or secondary mentor for 10 faculty who have received career development awards and who have then gone on to secure their own funding.
Danny's service to the community is expressed through his passion for coaching baseball. He has coached over 500 recreation league, travel league, and scholastic baseball games and he is the head coach of Smith Middle School, the 5-year reigning southern conference champions. Danny and his wife own a charitable non-profit that provides athletic and fitness opportunities for disadvantaged school-aged boys and girls.
Current Appointments & Affiliations
- Kiser-Arena Distinguished Professor, Pediatrics, Infectious Diseases, Pediatrics 2014
- Professor of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 2010
- Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2001
Contact Information
- 7044 Duke Clinical Research Institute, 2400 Pratt St, Durham, NC 27710
- Duke Box 17969, Duke Clinical Research Institute, Durham, NC 27710
-
(919) 668-7081
- Background
-
Education, Training, & Certifications
- Ph.D., University of North Carolina - Chapel Hill 2003
- Fellow, Pediatric Infectious Diseases, Pediatrics, Duke University 1998 - 2001
- M.P.H., University of North Carolina - Chapel Hill 2001
- Resident, Pediatrics, Children's Hospital 1995 - 1998
- M.D., University of Virginia 1995
-
Previous Appointments & Affiliations
- Chief, Division of Quantitative Sciences, Pediatrics, Pediatrics, Clinical Science Departments 2007 - 2010
- Associate Professor of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 2007 - 2010
- Associate Professor of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 2005 - 2007
- Assistant Professor of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 2002 - 2005
- Associate in the Department of Pediatrics, Pediatrics, Infectious Diseases, Pediatrics 2001 - 2002
- Instructor, Temporary in the Department of Pediatrics, Pediatrics, Clinical Science Departments 2001
-
Leadership & Clinical Positions at Duke
- Deputy Director, Duke Clinical Research Institute
- Recognition
-
In the News
-
SEP 16, 2022 School of Medicine Magnify -
MAR 10, 2022 Duke Health News -
DEC 29, 2021 -
OCT 8, 2021 Duke Health News -
JUN 30, 2021 Duke Health News -
MAY 13, 2021 ABC Science Collaborative -
FEB 11, 2021 School of Medicine Magnify -
JAN 27, 2021 -
JUL 8, 2014 -
JUL 8, 2014 Duke Today -
MAY 8, 2014 -
MAY 7, 2014 Duke Today
-
- Expertise
-
Global Scholarship
-
Research
-
- Research
-
Selected Grants
- HEAL Clinical Coordinating Resource Center for the Pain Management Effectiveness Research Network awarded by National Institutes of Health 2022 - 2027
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program awarded by University of North Carolina - Chapel Hill 2016 - 2026
- Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program awarded by National Institutes of Health 2021 - 2026
- Duke Summer Training in Academic Research (Duke's STAR) awarded by National Institutes of Health 2018 - 2024
- Duke Resident Physician-Scientist Program - NIAID awarded by National Institutes of Health 2018 - 2023
- Duration of post-discontinuation antibiotic exposures in premature infants and associated outcomes awarded by Thrasher Research Fund 2021 - 2023
- Duke Resident Physician-Scientist Program- NHLBI awarded by National Institutes of Health 2018 - 2023
- ACTIV -6 awarded by National Institutes of Health 2016 - 2023
- PTN 2.0 TO1 Core Function Activities - Option 4 awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development 2022 - 2023
- Duke CTSA (TL1) Year 5 awarded by National Institutes of Health 2018 - 2023
- ACTIV-1 awarded by Technical Resources International 2020 - 2023
- Bridging the Gap to Enhance Clinical Research Program (BIGGER) awarded by National Institutes of Health 2016 - 2022
- PTN 2.0 TO 1 Core Function Activities_Option 3 awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development 2021 - 2022
- PTN 2.0 TO 1 Core Function Activities_Option 3.1 awarded by National Institutes of Health 2021 - 2022
- ABCs of North Carolina Plan A awarded by NC Department of Public Instruction 2021 - 2022
- Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria awarded by National Institutes of Health 2011 - 2022
- Investigating polypharmacy-related adverse events in critically ill children using electronic health records and simulated drug levels awarded by National Institutes of Health 2017 - 2021
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program awarded by University of North Carolina - Chapel Hill 2020 - 2021
- PTN 2.0 TO 1 Core Function Activities_Option 2 awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development 2020 - 2021
- Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass awarded by National Institutes of Health 2017 - 2020
- Pediatric Trials Network_ Task Order 1_ Core Function Activities Option Period 1 awarded by National Institute for Child Health & Human Develo 2019 - 2020
- Mentorship of early-career pediatricians in quantitative methods and therapeutics awarded by National Institutes of Health 2018 - 2019
- Physiologically Based Pharmacokinetics in Critically Ill Children awarded by National Institutes of Health 2014 - 2019
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program awarded by University of North Carolina - Chapel Hill 2017 - 2019
- Pediatric Trials Network_ Task Order 1_ Core Function Activities awarded by National Institute for Child Health & Human Develo 2018 - 2019
- SOLI - Solithromycin Pediatric Development Program (Phase 2/3)- Labor & Sub Cost awarded by Cempra Pharmaceuticals, Inc. 2016 - 2018
- Duke Research Training Program for Pediatricians awarded by National Institutes of Health 2002 - 2018
- PTN TO #34: Program Management Support - Option 2 awarded by National Institute for Child Health & Human Develo 2017 - 2018
- PTN TO #34: Program Management Support - Option 2 Mod 1 (Mod 4) awarded by National Institute for Child Health & Human Develo 2017 - 2018
- PTN TO#47 (Protocol Development V) awarded by National Institute for Child Health & Human Develo 2017 - 2018
- Duke CTSA (UL1): Statistical methods for complex data in CV disease research awarded by National Institutes of Health 2013 - 2018
- NIH Summer Research Experience Programs (R25) awarded by National Institutes of Health 2013 - 2018
- PTN TO#42 HAP - Modification #1 awarded by National Institute for Child Health & Human Develo 2016 - 2017
- PTN TO#42 HAP awarded by National Institute for Child Health & Human Develo 2015 - 2017
- Pediatric Trials Network awarded by National Institutes of Health 2010 - 2017
- PTN TO #34: Program Management Support awarded by National Institute for Child Health & Human Develo 2016 - 2017
- PTN TO#14 (Mod #3) - Efficacy of sildenafil in premature infants with Pulmonary Hypertension awarded by National Institute for Child Health & Human Develo 2015 - 2017
- NRSA Training Grant for Clinical Pharmacology - Dallefeld and Chaparro awarded by University of North Carolina - Chapel Hill 2016 - 2017
- PTN Task Order #13: Pharmacokinetics of Antistaphylococcal Antibiotics in Infants awarded by National Institutes of Health 2012 - 2017
- Institutional Training Grant in Pediatric Infectious Disease awarded by National Institutes of Health 2011 - 2016
- PTN TO#40 (Protocol Development IV) awarded by National Institute for Child Health & Human Develo 2015 - 2016
- PTN Task Order #28 Baby Tape awarded by National Institutes of Health 2014 - 2016
- PTN Task Order #9: Midazolam awarded by National Institutes of Health 2011 - 2016
- The Duke Multidisciplinary Training Program in Pediatric Lung Disease awarded by National Institutes of Health 2010 - 2016
- PTN Task Order 34 - Program Management Support awarded by National Institutes of Health 2015 - 2016
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program awarded by University of North Carolina - Chapel Hill 2011 - 2016
- Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development awarded by National Institutes of Health 2014 - 2015
- PTN Task Order #5: Acyclovir awarded by National Institutes of Health 2011 - 2015
- PTN Task Order--Protocol Development III awarded by National Institutes of Health 2014 - 2015
- PTN Task Order #15: Fluconazole Safety Trials awarded by National Institutes of Health 2012 - 2015
- PTN Task Order #16: Pediatrix Safety Study awarded by National Institutes of Health 2012 - 2015
- Pharmacokinetics and Pharmacodynamics of Antibiotics in Premature Infants awarded by National Institutes of Health 2010 - 2015
- Multidisciplinary Neonatal Training Grant awarded by National Institutes of Health 2010 - 2015
- Institutional Training Grant in Pediatric Cardiology awarded by National Institutes of Health 2009 - 2015
- PTN Task Order #24: Protocol Development II awarded by National Institutes of Health 2013 - 2014
- PTN Task Order #14: Sildenafil study awarded by National Institutes of Health 2012 - 2014
- Prevention of Invasive Candidiasis: PK, Safety, and Neurodevelopmental Outcomes awarded by National Institutes of Health 2008 - 2014
- PTN Task Order #12 Protocol Development (RFTOPs) awarded by National Institutes of Health 2012 - 2014
- PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN HIGH RISK INFANTS awarded by National Institutes of Health 2009 - 2013
- PTN Task Order #8: TAPE awarded by National Institutes of Health 2011 - 2013
- PTN Task Order #10: Ampicillin awarded by National Institutes of Health 2011 - 2013
- PTN Task Order #11: Obesity Informatics Database awarded by National Institutes of Health 2011 - 2013
- CTSA UL awarded by National Institutes of Health 2006 - 2012
- Prevention of Invasive Candidiasis: PK, Safety, and Neurodevelopmental Outcomes awarded by Food and Drug Administration 2008 - 2012
- Complement Regulates the Humoral Response to HIV-1 awarded by National Institutes of Health 2009 - 2011
- North Carolina Collaborative PPRU Network awarded by National Institutes of Health 2004 - 2010
- Best Pharmaceutical for Children Act (BPCA): Use of Meropenem in Infants awarded by National Institutes of Health 2007 - 2010
- Early Diagnosis of Neonatal Candidiasis awarded by National Institutes of Health 2005 - 2009
- Clinical Predictors of Antiretroviral Failure awarded by National Institutes of Health 2002 - 2004
-
External Relationships
- AbbVie Pharmaceuticals
- PPD
- Syneos Health
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Moorthy, Ganga S., Angelique E. Boutzoukas, Daniel K. Benjamin, Philip M. Polgreen, Susan E. Beekmann, John S. Bradley, and Walter Dehority. “Defining Variability in Evaluation and Management of Children with Chronic Osteomyelitis.” J Pediatric Infect Dis Soc, January 23, 2023. https://doi.org/10.1093/jpids/piad007.Full Text Link to Item
-
Commander, Sarah Jane, Daniel K. Benjamin, Huali Wu, Elizabeth J. Thompson, Morgan Lane, Reese H. Clark, Rachel G. Greenberg, and Christoph P. Hornik. “Exposure-response Relationships of Metronidazole in Infants: Integration of Electronic Health Record Data With Population Pharmacokinetic Modeling-derived Exposure Simulation.” Pediatr Infect Dis J 42, no. 1 (January 1, 2023): 27–31. https://doi.org/10.1097/INF.0000000000003726.Full Text Link to Item
-
Boutzoukas, Angelique E., Rachel Olson, Mary Ann Sellers, Gwenyth Fischer, Chi D. Hornik, Omar Alibrahim, Kelechi Iheagwara, et al. “Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience.” Contemp Clin Trials 125 (December 25, 2022): 107067. https://doi.org/10.1016/j.cct.2022.107067.Full Text Link to Item
-
Corneli, Amy, Kevin McKenna, Carrie Dombeck, Nneka Molokwu, Jamilah Taylor, Lorraine Vergara, Daniel K. Benjamin, Kanecia O. Zimmerman, and Kanecia O. ABC Science Collaborative. “Caregivers of Black and Latino/a/x Students and School Personnel Perspectives on School-Based SARS-CoV-2 Testing: Implications for Testing and Test-to-Stay Programs in K-12 Schools.” J Sch Health, December 12, 2022. https://doi.org/10.1111/josh.13263.Full Text Link to Item
-
Lang, Jason E., Chi D. Hornik, Karen Martz, Juliana Jacangelo, Ravinder Anand, Rachel Greenberg, Christoph Hornik, et al. “Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.” Contemp Clin Trials Commun 30 (December 2022): 101025. https://doi.org/10.1016/j.conctc.2022.101025.Full Text Link to Item
-
Zimmerman, Kanecia O., Tracy G. Spears, Marjan Cobbaert, Felix Boakye-Agyeman, Huali Wu, Michael Cohen-Wolkowiez, Kevin M. Watt, et al. “Use of Electronic Health Records to Identify Exposure-Response Relationships in Critically Ill Children: An Example of Midazolam and Delirium.” J Pediatr Intensive Care 11, no. 4 (December 2022): 300–307. https://doi.org/10.1055/s-0041-1725148.Full Text Link to Item
-
Kalu, Ibukunoluwa C., Kanecia O. Zimmerman, Jennifer L. Goldman, Dana Keener Mast, Ashley M. Blakemore, Ganga Moorthy, Angelique E. Boutzoukas, et al. “SARS-CoV-2 Screening Testing Program for Safe In-person Learning in K-12 Schools.” J Pediatric Infect Dis Soc, November 22, 2022. https://doi.org/10.1093/jpids/piac119.Full Text Link to Item
-
Scott, Zeni, Diya M. Uthappa, Tara K. Mann, Hwasoon Kim, M. A. Brookhart, Laura Edwards, Zsolt Rak, Daniel K. Benjamin, Kanecia O. Zimmerman, and Kanecia O. ABC Science Collaborative. “Test-to-Stay in Kindergarten Through 12th Grade Schools After Household Exposure to Severe Acute Respiratory Syndrome Coronavirus 2.” J Sch Health, November 20, 2022. https://doi.org/10.1111/josh.13283.Full Text Link to Item
-
Campbell, Melissa M., Daniel K. Benjamin, Tara K. Mann, Alex Fist, Ashley Blakemore, Kylee S. Diaz, Hwasoon Kim, et al. “Test-to-Stay After SARS-CoV-2 Exposure: A Mitigation Strategy for Optionally Masked K-12 Schools.” Pediatrics 150, no. 5 (November 1, 2022). https://doi.org/10.1542/peds.2022-058200.Full Text Link to Item
-
Palm, M. E., C. J. Lindsell, H. P. Selker, D. Benjamin, G. Bernard, B. Bierer, T. Cohen, et al. “Sharing data among clinical trials of therapeutics in COVID-19: Barriers and facilitators to collaborating in a crisis.” Journal of Clinical and Translational Science 6, no. 1 (October 7, 2022). https://doi.org/10.1017/cts.2021.866.Full Text
-
Ko, Emily R., Kevin J. Anstrom, Reynold A. Panettieri, Anne M. Lachiewicz, Martin Maillo, Jane A. O’Halloran, Cynthia Boucher, et al. “Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.” Medrxiv, September 26, 2022. https://doi.org/10.1101/2022.09.22.22280247.Full Text Link to Item
-
O’Halloran, Jane, Eyal Kedar, Kevin J. Anstrom, Matthew W. McCarthy, Emily R. Ko, Patricia Segura Nunez, Cynthia Boucher, et al. “Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.” Medrxiv, September 26, 2022. https://doi.org/10.1101/2022.09.22.22280245.Full Text Link to Item
-
Randell, Rachel L., Daniel K. Benjamin, and Rachel G. Greenberg. “An Innovative Approach to Building an Effective and Efficient Pediatric Trial Network.” Hosp Pediatr 12, no. 9 (September 1, 2022): e309–11. https://doi.org/10.1542/hpeds.2022-006811.Full Text Link to Item
-
Gerhart, Jacqueline G., Fernando O. Carreño, Matthew Shane Loop, Craig R. Lee, Andrea N. Edginton, Jaydeep Sinha, Karan R. Kumar, et al. “Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity.” Clin Pharmacol Ther 112, no. 2 (August 2022): 391–403. https://doi.org/10.1002/cpt.2618.Full Text Link to Item
-
Boutzoukas, Angelique E., and Daniel K. Benjamin. “Author Response: Other Factors Potentially Contributing to the Number of Secondary Infections.” Pediatrics 150, no. 1 (July 1, 2022). https://doi.org/10.1542/peds.2022-057636B.Full Text Link to Item
-
Ericson, Jessica E., Daniel K. Benjamin, Felix Boakye-Agyeman, Stephen J. Balevic, C Michael Cotten, Felice Adler-Shohet, Matthew Laughon, et al. “Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease.” Early Hum Dev 170 (July 2022): 105616. https://doi.org/10.1016/j.earlhumdev.2022.105616.Full Text Open Access Copy Link to Item
-
Lang, Jason E., Christoph P. Hornik, Carrie Elliott, Adam Silverstein, Chi Hornik, Amira Al-Uzri, Miroslava Bosheva, et al. “Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia.” Pediatr Infect Dis J 41, no. 7 (July 1, 2022): 556–62. https://doi.org/10.1097/INF.0000000000003559.Full Text Link to Item
-
Le, Jennifer, Rachel G. Greenberg, YoungJun Yoo, Reese H. Clark, Daniel K. Benjamin, Kanecia O. Zimmerman, Michael Cohen-Wolkowiez, Kelly C. Wade, and Kelly C. Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee. “Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardship.” J Perinatol 42, no. 7 (July 2022): 959–64. https://doi.org/10.1038/s41372-022-01344-2.Full Text Link to Item
-
Boutzoukas, Angelique E., Kanecia O. Zimmerman, Moira Inkelas, M Alan Brookhart, Daniel K. Benjamin, Sabrina Butteris, Shawn Koval, et al. “School Masking Policies and Secondary SARS-CoV-2 Transmission.” Pediatrics 149, no. 6 (June 1, 2022). https://doi.org/10.1542/peds.2022-056687.Full Text Link to Item
-
Gerhart, Jacqueline G., Fernando O. Carreño, Jennifer L. Ford, Andrea N. Edginton, Eliana M. Perrin, Kevin M. Watt, William J. Muller, et al. “Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity.” Cpt Pharmacometrics Syst Pharmacol 11, no. 6 (June 2022): 778–91. https://doi.org/10.1002/psp4.12793.Full Text Link to Item
-
Zimmerman, Kanecia O., Brian Perry, Emily Hanlen-Rosado, Adora Nsonwu, Morgan D. Lane, Daniel K. Benjamin, Mara Becker, Amy Corneli, and Amy Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee. “Developing lay summaries and thank you notes in paediatric pragmatic clinical trials.” Health Expect 25, no. 3 (June 2022): 1029–37. https://doi.org/10.1111/hex.13448.Full Text Link to Item
-
Bekelman, Traci A., Susan L. Johnson, Rachel I. Steinberg, Corby K. Martin, Katherine A. Sauder, Sophie Luckett-Cole, Deborah H. Glueck, Daniel S. Hsia, Dana Dabelea, and Dana Environmental influences on Child Health Outcomes. “A Qualitative Analysis of the Remote Food Photography Method and the Automated Self-Administered 24-hour Dietary Assessment Tool for Assessing Children's Food Intake Reported by Parent Proxy.” J Acad Nutr Diet 122, no. 5 (May 2022): 961–73. https://doi.org/10.1016/j.jand.2021.11.001.Full Text Link to Item
-
Campbell, Melissa M., Daniel K. Benjamin, Tara Mann, Alex Fist, Hwasoon Kim, Laura Edwards, Zsolt Rak, et al. “Test-to-Stay After Exposure to SARS-CoV-2 in K-12 Schools.” Pediatrics 149, no. 5 (May 1, 2022). https://doi.org/10.1542/peds.2021-056045.Full Text Link to Item
-
Thakkar, Pavan V., Kanecia O. Zimmerman, Daniel K. Benjamin, and Ibukunoluwa C. Kalu. “SARS-CoV-2 Infections and Incidence at a North Carolina Pre-Kindergarten-12 School During In-Person Education: August 2020 to January 2021.” J Sch Health 92, no. 5 (May 2022): 461–68. https://doi.org/10.1111/josh.13148.Full Text Link to Item
-
Thakkar, Pavan V., Kanecia O. Zimmerman, M Alan Brookhart, Tyler R. Erickson, Daniel K. Benjamin, Ibukunoluwa C. Kalu, and Ibukunoluwa C. ABC Science Collaborative. “COVID-19 Incidence Among Sixth Through Twelfth Grade Students by Vaccination Status.” Pediatrics 149, no. 5 (May 1, 2022). https://doi.org/10.1542/peds.2022-056230.Full Text Link to Item
-
Dilts, N. A., F. E. Harrell, C. J. Lindsell, S. Nwosu, T. G. Stewart, M. S. Shotwell, J. M. Pulley, et al. “Securely sharing DSMB reports to speed decision making from multiple, concurrent, independent studies of similar treatments in COVID-19.” Journal of Clinical and Translational Science 6, no. 1 (April 11, 2022). https://doi.org/10.1017/cts.2022.387.Full Text
-
Boutzoukas, Angelique E., Kanecia O. Zimmerman, Daniel K. Benjamin, Gregory P. DeMuri, Ibukunoluwa C. Kalu, Michael J. Smith, Kathleen A. McGann, Shawn Koval, M Alan Brookhart, and Sabrina M. Butteris. “Secondary Transmission of COVID-19 in K-12 Schools: Findings From 2 States.” Pediatrics 149, no. 12 Suppl 2 (February 1, 2022). https://doi.org/10.1542/peds.2021-054268K.Full Text Link to Item
-
Boutzoukas, Angelique E., Kanecia O. Zimmerman, Daniel K. Benjamin, Kevin J. Chick, Jake Curtiss, and Tracy Beth Høeg. “Quarantine Elimination for K-12 Students With Mask-on-Mask Exposure to SARS-CoV-2.” Pediatrics 149, no. 12 Suppl 2 (February 1, 2022). https://doi.org/10.1542/peds.2021-054268L.Full Text Link to Item
-
Boutzoukas, Angelique E., Kanecia O. Zimmerman, Tara K. Mann, Ganga S. Moorthy, Ashley Blakemore, Kathleen A. McGann, Michael J. Smith, et al. “A School-Based SARS-CoV-2 Testing Program: Testing Uptake and Quarantine Length After In-School Exposures.” Pediatrics 149, no. 12 Suppl 2 (February 1, 2022). https://doi.org/10.1542/peds.2021-054268J.Full Text Link to Item
-
Gerhart, Jacqueline G., Fernando O. Carreño, Andrea N. Edginton, Jaydeep Sinha, Eliana M. Perrin, Karan R. Kumar, Aruna Rikhi, et al. “Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling.” Clin Pharmacokinet 61, no. 2 (February 2022): 307–20. https://doi.org/10.1007/s40262-021-01072-4.Full Text Link to Item
-
Goldman, Jennifer L., Jennifer E. Schuster, Vanessa F. Maier, Rohit Anand, Elizabeth E. Hill, Sabrina M. Butteris, Gregory P. DeMuri, et al. “Urban Classification, Not COVID-19 Community Rates, Was Associated With Modes of Learning in US K-12 Schools?” Pediatrics 149, no. 12 Suppl 2 (February 1, 2022). https://doi.org/10.1542/peds.2021-054268M.Full Text Link to Item
-
Moorthy, Ganga S., Tara K. Mann, Angelique E. Boutzoukas, Ashley Blakemore, M Alan Brookhart, Laura Edwards, Jennifer G. Jackman, et al. “Masking Adherence in K-12 Schools and SARS-CoV-2 Secondary Transmission.” Pediatrics 149, no. 12 Suppl 2 (February 1, 2022). https://doi.org/10.1542/peds.2021-054268I.Full Text Link to Item
-
Zimmerman, Kanecia O., Jennifer G. Jackman, and Daniel K. Benjamin. “From Research to Policy: Reopening K-12 Schools in North Carolina During the COVID-19 Pandemic.” Pediatrics 149, no. 12 Suppl 2 (February 1, 2022). https://doi.org/10.1542/peds.2021-054268E.Full Text Link to Item
-
Zimmerman, Kanecia O., Jennifer L. Goldman, Jennifer E. Schuster, Atenas Mena, Margo Quiriconi, Sabrina M. Butteris, Shawn Koval, et al. “Building a National Framework to Pair Scientists and Schools During a Global Pandemic.” Pediatrics 149, no. Suppl 2 (February 2022): e2021054268D. https://doi.org/10.1542/peds.2021-054268d.Full Text
-
Stark, Ashley, P Brian Smith, Christoph P. Hornik, Kanecia O. Zimmerman, Chi D. Hornik, Sidart Pradeep, Reese H. Clark, Daniel K. Benjamin, Matthew Laughon, and Rachel G. Greenberg. “Medication Use in the Neonatal Intensive Care Unit and Changes from 2010 to 2018.” J Pediatr 240 (January 2022): 66-71.e4. https://doi.org/10.1016/j.jpeds.2021.08.075.Full Text Link to Item
-
Stratakis, Nikos, Erika Garcia, Aruna Chandran, Tingju Hsu, Akram Alshawabkeh, Izzuddin M. Aris, Judy L. Aschner, et al. “The Role of Childhood Asthma in Obesity Development: A Nationwide US Multicohort Study.” Epidemiology 33, no. 1 (January 1, 2022): 131–40. https://doi.org/10.1097/EDE.0000000000001421.Full Text Link to Item
-
Boutzoukas, Angelique E., Kanecia O. Zimmerman, and Daniel K. Benjamin. “School Safety, Masking, and the Delta Variant.” Pediatrics, December 7, 2021. https://doi.org/10.1542/peds.2021-054396.Full Text Link to Item
-
Bekelman, Traci A., Dana Dabelea, Jody M. Ganiban, Andrew Law, Alexandra McGovern Reilly, Keri N. Althoff, Noel Mueller, et al. “Regional and sociodemographic differences in average BMI among US children in the ECHO program.” Obesity (Silver Spring) 29, no. 12 (December 2021): 2089–99. https://doi.org/10.1002/oby.23235.Full Text Link to Item
-
Boutzoukas, Angelique E., Kanecia O. Zimmerman, Daniel K. Benjamin, and Daniel K. ABC Science Collaborative. “School Safety, Masking, and the Delta Variant.” Pediatrics, October 8, 2021. https://doi.org/10.1542/peds.2021-054396.Full Text Link to Item
-
Zimmerman, Kanecia O., M Alan Brookhart, Ibukunoluwa C. Kalu, Angelique E. Boutzoukas, Kathleen A. McGann, Michael J. Smith, Gabriela M. Maradiaga Panayotti, et al. “Community SARS-CoV-2 Surge and Within-School Transmission.” Pediatrics 148, no. 4 (October 2021). https://doi.org/10.1542/peds.2021-052686.Full Text Link to Item
-
Maharaj, Anil R., Huali Wu, Kanecia O. Zimmerman, William J. Muller, Janice E. Sullivan, Catherine M. T. Sherwin, Julie Autmizguine, et al. “Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity.” Paediatr Drugs 23, no. 5 (September 2021): 499–513. https://doi.org/10.1007/s40272-021-00460-4.Full Text Link to Item
-
Lyall, Kristen, Mina Hosseini, Christine Ladd-Acosta, Xuejuan Ning, Diane Catellier, John N. Constantino, Lisa A. Croen, et al. “Distributional Properties and Criterion Validity of a Shortened Version of the Social Responsiveness Scale: Results from the ECHO Program and Implications for Social Communication Research.” J Autism Dev Disord 51, no. 7 (July 2021): 2241–53. https://doi.org/10.1007/s10803-020-04667-1.Full Text Link to Item
-
Miller, Laura E., Chris DeRienzo, P Brian Smith, Carl Bose, Reese H. Clark, C Michael Cotten, Daniel K. Benjamin, Chi D. Hornik, and Rachel G. Greenberg. “Association between neonatal intensive care unit medication safety practices, adverse events, and death.” J Perinatol 41, no. 7 (July 2021): 1739–44. https://doi.org/10.1038/s41372-020-00857-y.Full Text Link to Item
-
Corneli, Amy, Brian Perry, Daniel K. Benjamin, Kanecia O. Zimmerman, and Kanecia O. Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee. “Pediatric Trials Network: Stakeholder views on thanking families and providing study findings on pragmatic pediatric clinical research.” Contemp Clin Trials Commun 22 (June 2021): 100792. https://doi.org/10.1016/j.conctc.2021.100792.Full Text Link to Item
-
Smith, Michael J., Angelique Boutzoukas, Julie Autmizguine, Mark L. Hudak, Erin Zinkhan, Barry T. Bloom, Gloria Heresi, et al. “Antibiotic Safety and Effectiveness in Premature Infants With Complicated Intraabdominal Infections.” Pediatr Infect Dis J 40, no. 6 (June 1, 2021): 550–55. https://doi.org/10.1097/INF.0000000000003034.Full Text Link to Item
-
Le, Jennifer, Rachel G. Greenberg, Daniel K. Benjamin, YoungJun Yoo, Kanecia O. Zimmerman, Michael Cohen-Wolkowiez, Kelly C. Wade, and Kelly C. Administrative Core Committee of the Best Pharmaceuticals for Children Act–Pediatric Trials Network. “Prolonged Post-Discontinuation Antibiotic Exposure in Very Low Birth Weight Neonates at Risk for Early-Onset Sepsis.” J Pediatric Infect Dis Soc 10, no. 5 (May 28, 2021): 615–21. https://doi.org/10.1093/jpids/piaa172.Full Text Link to Item
-
Abdel-Rahman, Susan M., Ian M. Paul, Chi Hornik, Janice E. Sullivan, Kelly Wade, Paula Delmore, Gaurav Sharma, Daniel K. Benjamin, and Kanecia O. Zimmerman. “Racial and Ethnic Diversity in Studies Funded Under the Best Pharmaceuticals for Children Act.” Pediatrics 147, no. 5 (May 2021). https://doi.org/10.1542/peds.2020-042903.Full Text Link to Item
-
Boutzoukas, Angelique E., Daniel K. Benjamin, and Kanecia O. Zimmerman. “Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use.” Pediatrics 147, no. 5 (May 2021). https://doi.org/10.1542/peds.2021-050212.Full Text Link to Item
-
Greenberg, Rachel G., Lori Poole, Daniel E. Ford, Daniel Hanley, Harry P. Selker, Karen Lane, J Michael Dean, et al. “Response of the trial innovation network to the COVID-19 pandemic.” J Clin Transl Sci 5, no. 1 (April 20, 2021): e100. https://doi.org/10.1017/cts.2021.782.Full Text Link to Item
-
Aleem, Samia, Cliff Robbins, Brianna Murphy, Stephen Elliott, Christiana Akinyemi, Nicholas Paredes, Veeral N. Tolia, et al. “The use of supplemental hydrocortisone in the management of persistent pulmonary hypertension of the newborn.” J Perinatol 41, no. 4 (April 2021): 794–800. https://doi.org/10.1038/s41372-021-00943-9.Full Text Link to Item
-
Zimmerman, Kanecia O., Ibukunoluwa C. Akinboyo, M Alan Brookhart, Angelique E. Boutzoukas, Kathleen A. McGann, Michael J. Smith, Gabriela Maradiaga Panayotti, et al. “Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools.” Pediatrics 147, no. 4 (April 2021). https://doi.org/10.1542/peds.2020-048090.Full Text Link to Item
-
Dorismond, Christina, Senyene E. Hunter, Peggy P. McNaull, Kanecia O. Zimmerman, Daniel K. Benjamin, Rachel G. Greenberg, Kristin M. Corey, Matthew M. Laughon, and Wesley M. Jackson. “Wide range of perioperative drugs and doses used in inguinal hernia repairs for premature infants.” J Perinatol 41, no. 3 (March 2021): 577–81. https://doi.org/10.1038/s41372-020-00864-z.Full Text Link to Item
-
Williams, Phoebe C. M., John Bradley, Emmanuel Roilides, Linus Olson, Sheldon Kaplan, Irja Lutsar, Carlo Giaquinto, Daniel K. Benjamin, and Mike Sharland. “Harmonising regulatory approval for antibiotics in children.” Lancet Child Adolesc Health 5, no. 2 (February 2021): 96–98. https://doi.org/10.1016/S2352-4642(20)30365-5.Full Text Link to Item
-
Boutzoukas, Angelique E., Ibukunoluwa C. Akinboyo, Charlene A. Wong, Daniel K. Benjamin, and Kanecia O. Zimmerman. “Impact of COVID-19-related School Closures on the Drivers of Child Health.” N C Med J 82, no. 1 (2021): 50–56. https://doi.org/10.18043/ncm.82.1.50.Full Text Link to Item
-
Polcwiartek, Laura Bech, P Brian Smith, Daniel K. Benjamin, Kanecia Zimmerman, Alycia Love, Lance Tiu, Sylvia Murray, et al. “Early-onset sepsis in term infants admitted to neonatal intensive care units (2011-2016).” J Perinatol 41, no. 1 (January 2021): 157–63. https://doi.org/10.1038/s41372-020-00860-3.Full Text Link to Item
-
Salerno, Sara N., Andrea Edginton, Jacqueline G. Gerhart, Matthew M. Laughon, Namasivayam Ambalavanan, Gregory M. Sokol, Chi D. Hornik, et al. “Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants.” Clin Pharmacol Ther 109, no. 1 (January 2021): 253–62. https://doi.org/10.1002/cpt.1990.Full Text Link to Item
-
Ge, Shufan, Susan R. Mendley, Jacqueline G. Gerhart, Chiara Melloni, Christoph P. Hornik, Janice E. Sullivan, Andrew Atz, et al. “Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents.” Clin Transl Sci 13, no. 6 (November 2020): 1189–98. https://doi.org/10.1111/cts.12803.Full Text Link to Item
-
Maharaj, Anil R., Huali Wu, Christoph P. Hornik, Stephen J. Balevic, Chi D. Hornik, P Brian Smith, Daniel Gonzalez, et al. “Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.” Jama Pediatr 174, no. 10 (October 1, 2020): e202422. https://doi.org/10.1001/jamapediatrics.2020.2422.Full Text Link to Item
-
Commander, Sarah Jane, Jamie Gao, Erin K. Zinkhan, Gloria Heresi, Sherry E. Courtney, Adrian P. Lavery, Paula Delmore, et al. “Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections.” Pediatr Infect Dis J 39, no. 9 (September 2020): e245–48. https://doi.org/10.1097/INF.0000000000002698.Full Text Link to Item
-
Ericson, Jessica E., Christoph P. Hornik, Rachel G. Greenberg, Reese H. Clark, Adriana H. Tremoulet, Jennifer Le, Michael Cohen-Wolkowiez, P Brian Smith, Daniel K. Benjamin, and Daniel K. Best Pharmaceuticals for Children Act – Pediatric Trials Network. “Paradoxical Antibiotic Effect of Ampicillin: Use of a Population Pharmacokinetic Model to Evaluate a Clinical Correlate of the Eagle Effect in Infants With Bacteremia.” Pediatr Infect Dis J 39, no. 8 (August 2020): 725–29. https://doi.org/10.1097/INF.0000000000002663.Full Text Link to Item
-
Ericson, Jessica E., John McGuire, Marian G. Michaels, Adam Schwarz, Robert Frenck, Jaime G. Deville, Swati Agarwal, et al. “Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Children: A Prospective Natural History and Case-Control Study.” Pediatr Infect Dis J 39, no. 8 (August 2020): 658–64. https://doi.org/10.1097/INF.0000000000002642.Full Text Link to Item
-
Jackson, Wesley, Genevieve Taylor, Nicolas A. Bamat, Kanecia Zimmerman, Reese Clark, Daniel K. Benjamin, Matthew M. Laughon, Rachel G. Greenberg, and Christoph P. Hornik. “Outcomes associated with surfactant in more mature and larger premature infants with respiratory distress syndrome.” J Perinatol 40, no. 8 (August 2020): 1171–77. https://doi.org/10.1038/s41372-020-0625-1.Full Text Link to Item
-
Stark, Ashley, Julie Childers, Morgan England, Reese H. Clark, Matthew Laughon, Michael Cohen-Wolkowiez, Daniel K. Benjamin, P Brian Smith, Kelly Wade, and Rachel G. Greenberg. “Dosing of Antimicrobials in the Neonatal Intensive Care Unit: Does Clinical Practice Reflect Pharmacokinetics-based Recommendations?” Pediatr Infect Dis J 39, no. 8 (August 2020): 713–17. https://doi.org/10.1097/INF.0000000000002657.Full Text Link to Item
-
Xie, Rujia, Lynn McFadyen, Susan Raber, Robert Swanson, Margaret Tawadrous, Heidi Leister-Tebbe, Michael Cohen-Wolkowiez, Daniel K. Benjamin, and Ping Liu. “Population Analysis of Anidulafungin in Infants to Older Adults With Confirmed or Suspected Invasive Candidiasis.” Clin Pharmacol Ther 108, no. 2 (August 2020): 316–25. https://doi.org/10.1002/cpt.1831.Full Text Link to Item
-
Gray, Keyaria D., Julia A. Messina, Christopher Cortina, Tanasha Owens, Madeline Fowler, Matthew Foster, Simi Gbadegesin, et al. “Probiotic Use and Safety in the Neonatal Intensive Care Unit: A Matched Cohort Study.” J Pediatr 222 (July 2020): 59-64.e1. https://doi.org/10.1016/j.jpeds.2020.03.051.Full Text Link to Item
-
Donoghue, Aaron J., Maybelle Kou, Grace L. Good, Carmel Eiger, Mark Nash, Fred M. Henretig, Helen Stacks, et al. “Impact of Personal Protective Equipment on Pediatric Cardiopulmonary Resuscitation Performance: A Controlled Trial.” Pediatr Emerg Care 36, no. 6 (June 2020): 267–73. https://doi.org/10.1097/PEC.0000000000002109.Full Text Link to Item
-
Puia-Dumitrescu, Mihai, Noelle Younge, Daniel K. Benjamin, Katie Lawson, Cordelia Hume, Kennedy Hill, Jonathan Mengistu, et al. “Medications and in-hospital outcomes in infants born at 22-24 weeks of gestation.” J Perinatol 40, no. 5 (May 2020): 781–89. https://doi.org/10.1038/s41372-020-0614-4.Full Text Link to Item
-
Drolet, Beth A., Felix Boakye-Agyeman, Barrie Harper, Kristen Holland, Andrew Lewandowski, Nicole Stefanko, Chiara Melloni, and Chiara Pediatric Trials Network Steering Committee (See Acknowledgments for a listing of committee members.). “Systemic timolol exposure following topical application to infantile hemangiomas.” J Am Acad Dermatol 82, no. 3 (March 2020): 733–36. https://doi.org/10.1016/j.jaad.2019.02.029.Full Text Link to Item
-
Hornik, Christoph P., Amy A. Gelfand, Christina L. Szperka, Tara Pezzuto, Amanda Utevsky, Shirley Kessel, Susan McCune, John J. Alexander, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Development of a Prospective Real-World Data Clinical Registry of Children and Adolescents With Migraine.” Headache 60, no. 2 (February 2020): 405–15. https://doi.org/10.1111/head.13714.Full Text Link to Item
-
Puia-Dumitrescu, Mihai, Daniel K. Benjamin, P Brian Smith, Rachel G. Greenberg, Nada Abuzaid, Winsome Andrews, Kris Chellani, et al. “Impact of Gastrostomy Tube Placement on Short-Term Weight Gain in Hospitalized Premature Infants.” Jpen J Parenter Enteral Nutr 44, no. 2 (February 2020): 355–60. https://doi.org/10.1002/jpen.1539.Full Text Link to Item
-
Padula, Amy M., Catherine Monk, Patricia A. Brennan, Ann Borders, Emily S. Barrett, Cindy T. McEvoy, Sophie Foss, et al. “A review of maternal prenatal exposures to environmental chemicals and psychosocial stressors-implications for research on perinatal outcomes in the ECHO program.” J Perinatol 40, no. 1 (January 2020): 10–24. https://doi.org/10.1038/s41372-019-0510-y.Full Text Link to Item
-
Thompson, Elizabeth J., Daniel K. Benjamin, Rachel G. Greenberg, Karan R. Kumar, Kanecia O. Zimmerman, Matthew Laughon, Reese H. Clark, P Brian Smith, and Christoph P. Hornik. “Pharmacoepidemiology of Furosemide in the Neonatal Intensive Care Unit.” Neonatology 117, no. 6 (2020): 780–84. https://doi.org/10.1159/000510657.Full Text Link to Item
-
Gonzalez, Daniel, Matthew M. Laughon, P Brian Smith, Shufan Ge, Namasivayam Ambalavanan, Andrew Atz, Gregory M. Sokol, et al. “Population pharmacokinetics of sildenafil in extremely premature infants.” Br J Clin Pharmacol 85, no. 12 (December 2019): 2824–37. https://doi.org/10.1111/bcp.14111.Full Text Link to Item
-
Petraitis, Vidmantas, Ruta Petraitiene, Jessica M. Valdez, Vasilios Pyrgos, Martin J. Lizak, Brenda A. Klaunberg, Darius Kalasauskas, et al. “Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous Candida Meningoencephalitis.” Antimicrob Agents Chemother 63, no. 12 (October 7, 2019). https://doi.org/10.1128/AAC.01626-19.Full Text Link to Item
-
Thompson, Elizabeth J., Huali Wu, Chiara Melloni, Stephen Balevic, Janice E. Sullivan, Matthew Laughon, Kira M. Clark, et al. “Population Pharmacokinetics of Doxycycline in Children.” Antimicrob Agents Chemother 63, no. 12 (September 23, 2019). https://doi.org/10.1128/AAC.01508-19.Full Text Link to Item
-
Balevic, Stephen J., P Brian Smith, Daniela Testoni, Huali Wu, Kim L. R. Brouwer, Kanecia O. Zimmerman, Nazario D. Rivera-Chaparro, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Cefazolin pharmacokinetics in premature infants.” J Perinatol 39, no. 9 (September 2019): 1213–18. https://doi.org/10.1038/s41372-019-0368-z.Full Text Link to Item
-
Puia-Dumitrescu, Mihai, P Brian Smith, Jian Zhao, Angela Soriano, Elizabeth H. Payne, Barrie Harper, Ellen Bendel-Stenzel, et al. “Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.” J Pediatr 211 (August 2019): 27-32.e1. https://doi.org/10.1016/j.jpeds.2019.04.028.Full Text Link to Item
-
Zimmerman, Kanecia O., Daniel K. Benjamin, and Mara L. Becker. “Neonatal Therapeutics: Considerations for Dosing.” Am J Perinatol 36, no. S 02 (July 2019): S18–21. https://doi.org/10.1055/s-0039-1691772.Full Text Link to Item
-
Smith, P Brian, C Michael Cotten, Mark L. Hudak, Janice E. Sullivan, Brenda B. Poindexter, Michael Cohen-Wolkowiez, Felix Boakye-Agyeman, et al. “Rifampin Pharmacokinetics and Safety in Preterm and Term Infants.” Antimicrob Agents Chemother 63, no. 6 (June 2019). https://doi.org/10.1128/AAC.00284-19.Full Text Link to Item
-
Greenberg, Rachel G., Sreepriya Gayam, Destiny Savage, Andrew Tong, Daniel Gorham, Ari Sholomon, Reese H. Clark, et al. “Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants.” J Pediatr 208 (May 2019): 134-140.e2. https://doi.org/10.1016/j.jpeds.2018.11.043.Full Text Link to Item
-
Watt, Kevin M., Christoph P. Hornik, Stephen J. Balevic, Gratias Mundakel, C Michael Cotten, Barrie Harper, Daniel K. Benjamin, et al. “Pharmacokinetics of ticarcillin-clavulanate in premature infants.” Br J Clin Pharmacol 85, no. 5 (May 2019): 1021–27. https://doi.org/10.1111/bcp.13882.Full Text Link to Item
-
Rivera-Chaparro, Nazario D., Jessica Ericson, Huali Wu, P Brian Smith, Reese H. Clark, Daniel K. Benjamin, Michael Cohen-Wolkowiez, and Rachel G. Greenberg. “Safety, Effectiveness and Exposure-response of Micafungin in Infants: Application of an Established Pharmacokinetics Model to Electronic Health Records.” Pediatr Infect Dis J 38, no. 2 (February 2019): e26–28. https://doi.org/10.1097/INF.0000000000002045.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, and Daniel K. Benjamin. “Development of Therapeutics for Children-A Tricky Balancing Act.” Jama Pediatr 173, no. 1 (January 1, 2019): 18–19. https://doi.org/10.1001/jamapediatrics.2018.4026.Full Text Link to Item
-
Autmizguine, Julie, P Brian Smith, Kristi Prather, Catherine Bendel, Girija Natarajan, Margarita Bidegain, David A. Kaufman, et al. “Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.” J Antimicrob Chemother 73, no. 12 (December 1, 2018): 3482–87. https://doi.org/10.1093/jac/dky353.Full Text Link to Item
-
Puia-Dumitrescu, Mihai, Olivia M. Bretzius, Nia Brown, James A. Fitz-Henley, Rebecca Ssengonzi, Caroline S. Wechsler, Keyaria D. Gray, et al. “Evaluation of Gentamicin Exposure in the Neonatal Intensive Care Unit and Hearing Function at Discharge.” J Pediatr 203 (December 2018): 131–36. https://doi.org/10.1016/j.jpeds.2018.07.101.Full Text Link to Item
-
Gray, Keyaria D., Kathryn Dudash, Carla Escobar, Colman Freel, Tylah Harrison, Chandler McMillan, Mihai Puia-Dumitrescu, et al. “Prevalence and safety of diazoxide in the neonatal intensive care unit.” J Perinatol 38, no. 11 (November 2018): 1496–1502. https://doi.org/10.1038/s41372-018-0218-4.Full Text Link to Item
-
Ku, Lawrence C., Christoph P. Hornik, Ryan J. Beechinor, James M. Chamberlain, Jeffrey T. Guptill, Barrie Harper, Edmund V. Capparelli, et al. “Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status Epilepticus.” Cpt Pharmacometrics Syst Pharmacol 7, no. 11 (November 2018): 718–27. https://doi.org/10.1002/psp4.12349.Full Text Link to Item
-
Kumar, Karan R., David A. Clark, Evan M. Kim, Jasmine D. Perry, Kaylyn Wright, Sheikisha A. Thomas, Elizabeth J. Thompson, et al. “Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants.” J Pediatr 202 (November 2018): 56-62.e2. https://doi.org/10.1016/j.jpeds.2018.07.024.Full Text Link to Item
-
Romaine, Andrew, Reese H. Clark, Briana R. Davis, Kaitlin Hendershot, Vance Kite, Madeleine Laughon, Isaac Updike, et al. “Predictors of Prolonged Breast Milk Provision to Very Low Birth Weight Infants.” J Pediatr 202 (November 2018): 23-30.e1. https://doi.org/10.1016/j.jpeds.2018.07.001.Full Text Link to Item
-
Steinbach, William J., Daniel K. Benjamin, and John W. Sleasman. “Funding Pediatric Subspecialty Training: Are T32 Grants the Future?” J Pediatr 202 (November 2018): 4-7.e1. https://doi.org/10.1016/j.jpeds.2018.08.035.Full Text Link to Item
-
Benjamin, Daniel K., David A. Kaufman, William W. Hope, P Brian Smith, Antonio Arrieta, Paolo Manzoni, Laura L. Kovanda, et al. “A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.” Pediatr Infect Dis J 37, no. 10 (October 2018): 992–98. https://doi.org/10.1097/INF.0000000000001996.Full Text Link to Item
-
Shakhnovich, Valentina, P. Brian Smith, Jeffrey T. Guptill, Laura P. James, David N. Collier, Huali Wu, Chad E. Livingston, et al. “A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents.” Paediatr Drugs 20, no. 5 (October 2018): 483–95. https://doi.org/10.1007/s40272-018-0305-1.Full Text Link to Item
-
Tsakiri, Sophia, Chiamaka Aneji, Christine Domonoske, Lynnette Mazur, Daniel K. Benjamin, and Susan H. Wootton. “Voriconazole Treatment for an Infant With Intractable Candida glabrata Meningitis.” Pediatr Infect Dis J 37, no. 10 (October 2018): 999–1001. https://doi.org/10.1097/INF.0000000000002073.Full Text Link to Item
-
Wang, Laura A., P Brian Smith, Matthew Laughon, Ronald N. Goldberg, Lawrence C. Ku, Kanecia O. Zimmerman, Stephen Balevic, et al. “Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants.” Early Hum Dev 125 (October 2018): 26–30. https://doi.org/10.1016/j.earlhumdev.2018.08.009.Full Text Link to Item
-
Autmizguine, Julie, Sylvia Tan, Michael Cohen-Wolkowiez, C Michael Cotten, Nathan Wiederhold, Ronald N. Goldberg, Ira Adams-Chapman, et al. “Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.” Pediatr Infect Dis J 37, no. 9 (September 2018): 923–29. https://doi.org/10.1097/INF.0000000000001913.Full Text Link to Item
-
Thaden, Joshua T., Karen Chiswell, Ian Jaffe, Stephen P. Bergin, William E. Yang, Andrew Romaine, Jamie Roberts, et al. “Pediatric Antibacterial and Antifungal Trials From 2007 to 2017.” Pediatrics 142, no. 3 (September 2018). https://doi.org/10.1542/peds.2017-1849.Full Text Open Access Copy Link to Item
-
Ariagno, Ronald L., Henry C. Lee, David K. Stevenson, Daniel K. Benjamin, P Brian Smith, Marilyn B. Escobedo, and Dilip R. Bhatt. “A directory for neonatal intensive care: potential for facilitating network-based research in neonatology.” J Perinatol 38, no. 8 (August 2018): 954–58. https://doi.org/10.1038/s41372-018-0097-8.Full Text Link to Item
-
Bernard, Gordon R., Paul A. Harris, Jill M. Pulley, Daniel K. Benjamin, Jonathan Michael, Daniel E. Ford, Daniel F. Hanley, Harry P. Selker, and Consuelo H. Wilkins. “A collaborative, academic approach to optimizing the national clinical research infrastructure: The first year of the Trial Innovation Network.” J Clin Transl Sci 2, no. 4 (August 2018): 187–92. https://doi.org/10.1017/cts.2018.319.Full Text Link to Item
-
Gonzalez, Daniel, Laura P. James, Amira Al-Uzri, Miroslava Bosheva, Felice C. Adler-Shohet, Susan R. Mendley, John S. Bradley, et al. “Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.” Antimicrob Agents Chemother 62, no. 8 (August 2018). https://doi.org/10.1128/AAC.00692-18.Full Text Link to Item
-
Gonzalez, Daniel, Laura P. James, Amira Al-Uzri, Miroslava Bosheva, Felice C. Adler-Shohet, Susan R. Mendley, John S. Bradley, et al. “Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.” Antimicrobial Agents and Chemotherapy 62, no. 8 (August 1, 2018). https://doi.org/10.1128/AAC.00692-18;e00692-18.Full Text Link to Item
-
Kovanda, Laura L., Thomas J. Walsh, Daniel K. Benjamin, Antonio Arrieta, David A. Kaufman, P Brian Smith, Paolo Manzoni, et al. “Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.” Pediatr Infect Dis J 37, no. 6 (June 2018): 580–85. https://doi.org/10.1097/INF.0000000000001957.Full Text Link to Item
-
Smith, Brian, Susan Knox, and Daniel K. Benjamin. “Coordination of the Environmental influences on Child Health Outcomes program: so the whole is greater than the sum of its parts.” Curr Opin Pediatr 30, no. 2 (April 2018): 263–68. https://doi.org/10.1097/MOP.0000000000000598.Full Text Link to Item
-
Corneli, Amy, Chris Wheeler, John Bradley, Breck Gamel, Sumathi Nambiar, Gary J. Noel, Li Lin, Jamie N. Roberts, and Daniel K. Benjamin. “Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigators.” Contemp Clin Trials Commun 9 (March 2018): 115–20. https://doi.org/10.1016/j.conctc.2018.01.003.Full Text Link to Item
-
Greenberg, Rachel G., Amy Corneli, John Bradley, John Farley, Hasan S. Jafri, Li Lin, Sumathi Nambiar, et al. “Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative.” Contemp Clin Trials Commun 9 (March 2018): 7–12. https://doi.org/10.1016/j.conctc.2017.11.006.Full Text Link to Item
-
Greenberg, Rachel G., Breck Gamel, Diane Bloom, John Bradley, Hasan S. Jafri, Denise Hinton, Sumathi Nambiar, et al. “Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative.” Contemp Clin Trials Commun 9 (March 2018): 33–39. https://doi.org/10.1016/j.conctc.2017.11.005.Full Text Link to Item
-
Le, Jennifer, Brenda Poindexter, Janice E. Sullivan, Matthew Laughon, Paula Delmore, Martha Blackford, Ram Yogev, et al. “Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.” Ther Drug Monit 40, no. 1 (February 2018): 103–8. https://doi.org/10.1097/FTD.0000000000000466.Full Text Link to Item
-
Shakhnovich, Valentina, P Brian Smith, Jeffrey T. Guptill, Laura P. James, David N. Collier, Huali Wu, Chad E. Livingston, Jian Zhao, Gregory L. Kearns, and Gregory L. Best Pharmaceuticals for Children Act – Pediatric Trials Network. “Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures.” J Pediatr 193 (February 2018): 102-108.e1. https://doi.org/10.1016/j.jpeds.2017.10.011.Full Text Link to Item
-
Testoni, Daniela, Christoph P. Hornik, Ruth Guinsburg, Reese H. Clark, Rachel G. Greenberg, Daniel K. Benjamin, and P Brian Smith. “Early lumbar puncture and risk of intraventricular hemorrhage in very low birth weight infants.” Early Hum Dev 117 (February 2018): 1–6. https://doi.org/10.1016/j.earlhumdev.2017.11.013.Full Text Link to Item
-
Ward, Robert M., Daniel K. Benjamin, Jonathan M. Davis, Richard L. Gorman, Ralph Kauffman, Gregory L. Kearns, Mary Dianne Murphy, and Catherine M. T. Sherwin. “The Need for Pediatric Drug Development.” J Pediatr 192 (January 2018): 13–21. https://doi.org/10.1016/j.jpeds.2017.08.011.Full Text Link to Item
-
Watt, Kevin M., Debbie Avant, Jennifer Sherwin, Daniel K. Benjamin, Christoph Hornik, Jennifer S. Li, and P Brian Smith. “Effect of renal function on antihypertensive drug safety and efficacy in children.” Pediatr Nephrol 33, no. 1 (January 2018): 139–46. https://doi.org/10.1007/s00467-017-3763-8.Full Text Link to Item
-
Hwang, Michael F., Ryan J. Beechinor, Kelly C. Wade, Daniel K. Benjamin, P Brian Smith, Christoph P. Hornik, Edmund V. Capparelli, et al. “External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models.” Antimicrob Agents Chemother 61, no. 12 (December 2017). https://doi.org/10.1128/AAC.01352-17.Full Text Link to Item
-
Watt, Kevin M., Michael Cohen-Wolkowiez, Duane C. Williams, Desiree K. Bonadonna, Ira M. Cheifetz, Dhiren Thakker, Daniel K. Benjamin, and Kim L. R. Brouwer. “Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit.” J Extra Corpor Technol 49, no. 3 (September 2017): 150–59.Link to Item
-
Gonzalez, Daniel, James M. Chamberlain, Jeffrey T. Guptill, Michael Cohen-Wolkowiez, Barrie Harper, Jian Zhao, Edmund V. Capparelli, and Edmund V. Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee. “Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus.” Clin Pharmacokinet 56, no. 8 (August 2017): 941–51. https://doi.org/10.1007/s40262-016-0486-0.Full Text Link to Item
-
Wynn, James L., Matthew S. Kelly, Daniel K. Benjamin, Reese H. Clark, Rachel Greenberg, and P Brian Smith. “Timing of Multiorgan Dysfunction among Hospitalized Infants with Fatal Fulminant Sepsis.” Am J Perinatol 34, no. 7 (June 2017): 633–39. https://doi.org/10.1055/s-0036-1597130.Full Text Link to Item
-
Ericson, Jessica E., Martyn Gostelow, Julie Autmizguine, Christoph P. Hornik, Reese H. Clark, Daniel K. Benjamin, P Brian Smith, and P Brian Pediatric Trials Network Executive Committee and Investigators. “Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections.” Pediatr Infect Dis J 36, no. 4 (April 2017): 369–73. https://doi.org/10.1097/INF.0000000000001451.Full Text Link to Item
-
Lee, Jin A., Brooke Sauer, William Tuminski, Jiyu Cheong, John Fitz-Henley, Megan Mayers, Chidera Ezuma-Igwe, et al. “Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia.” Am J Perinatol 34, no. 5 (April 2017): 458–64. https://doi.org/10.1055/s-0036-1593349.Full Text Link to Item
-
Smith, Michael J., Daniel Gonzalez, Jennifer L. Goldman, Ram Yogev, Janice E. Sullivan, Michael D. Reed, Ravinder Anand, et al. “Pharmacokinetics of Clindamycin in Obese and Nonobese Children.” Antimicrob Agents Chemother 61, no. 4 (April 2017). https://doi.org/10.1128/AAC.02014-16.Full Text Link to Item
-
Mankouski, Anastasiya, Crystal Kantores, Mathew J. Wong, Julijana Ivanovska, Amish Jain, Eric J. Benner, Stanley N. Mason, A Keith Tanswell, Richard L. Auten, and Robert P. Jankov. “Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD.” Am J Physiol Lung Cell Mol Physiol 312, no. 2 (February 1, 2017): L208–16. https://doi.org/10.1152/ajplung.00463.2016.Full Text Link to Item
-
Parente, V., R. H. Clark, L. Ku, C. Fennell, M. Johnson, E. Morris, A. Romaine, et al. “Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing.” J Perinatol 37, no. 2 (February 2017): 157–61. https://doi.org/10.1038/jp.2016.201.Full Text Link to Item
-
Wang, Laura A., Daniel Gonzalez, J Steven Leeder, Rachel F. Tyndale, Robin E. Pearce, Daniel K. Benjamin, Gregory L. Kearns, Michael Cohen-Wolkowiez, and Michael Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee. “Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation.” J Clin Pharmacol 57, no. 2 (February 2017): 230–34. https://doi.org/10.1002/jcph.797.Full Text Link to Item
-
Zhang, Cecilia J., Martin Bidlingmaier, Mekibib Altaye, Laura C. Page, David D’Alessio, Matthias H. Tschöp, and Jenny Tong. “Acute administration of acyl, but not desacyl ghrelin, decreases blood pressure in healthy humans.” Eur J Endocrinol 176, no. 2 (February 2017): 123–32. https://doi.org/10.1530/EJE-16-0789.Full Text Link to Item
-
Lloyd, Jessica C., Christoph P. Hornik, Daniel K. Benjamin, Reese H. Clark, Jonathan C. Routh, and P Brian Smith. “Incidence of Breakthrough Urinary Tract Infection in Hospitalized Infants Receiving Antibiotic Prophylaxis.” Clin Pediatr (Phila) 56, no. 1 (January 2017): 65–70. https://doi.org/10.1177/0009922816638664.Full Text Link to Item
-
Smith, P Brian, Daniel K. Benjamin, and Ann M. Reed. “The Role of a Division of Quantitative Sciences Division in Enhancing Academic Productivity of a Department of Pediatrics.” J Pediatr 180 (January 2017): 4–5. https://doi.org/10.1016/j.jpeds.2016.09.042.Full Text Link to Item
-
Autmizguine, Julie, Christoph P. Hornik, Daniel K. Benjamin, Kim L. R. Brouwer, Susan R. Hupp, Michael Cohen-Wolkowiez, and Kevin M. Watt. “Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation.” Pediatr Infect Dis J 35, no. 11 (November 2016): 1204–10. https://doi.org/10.1097/INF.0000000000001268.Full Text Link to Item
-
Hornik, Christoph P., Daniel K. Benjamin, P Brian Smith, Michael J. Pencina, Adriana H. Tremoulet, Edmund V. Capparelli, Jessica E. Ericson, Reese H. Clark, Michael Cohen-Wolkowiez, and Michael Best Pharmaceuticals for Children Act—Pediatric Trials Network. “Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.” J Pediatr 178 (November 2016): 125-129.e1. https://doi.org/10.1016/j.jpeds.2016.07.011.Full Text Link to Item
-
Ericson, Jessica E., David A. Kaufman, Stephen D. Kicklighter, Jatinder Bhatia, Daniela Testoni, Jamie Gao, P Brian Smith, et al. “Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.” Clin Infect Dis 63, no. 5 (September 1, 2016): 604–10. https://doi.org/10.1093/cid/ciw363.Full Text Link to Item
-
Folgori, Laura, Julia Bielicki, Beatriz Ruiz, Mark A. Turner, John S. Bradley, Daniel K. Benjamin, Theoklis E. Zaoutis, et al. “Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review.” Lancet Infect Dis 16, no. 9 (September 2016): e178–89. https://doi.org/10.1016/S1473-3099(16)00069-4.Full Text Link to Item
-
Momper, Jeremiah D., Edmund V. Capparelli, Kelly C. Wade, Anand Kantak, Ramasubbareddy Dhanireddy, James J. Cummings, Jonathan H. Nedrelow, et al. “Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.” Antimicrob Agents Chemother 60, no. 9 (September 2016): 5539–45. https://doi.org/10.1128/AAC.00963-16.Full Text Link to Item
-
Zimmerman, Kanecia, Martin Putera, Christoph P. Hornik, P. Brian Smith, Daniel K. Benjamin, Yeruk Mulugeta, Gilbert J. Burckart, Michael Cohen-Wolkowiez, and Daniel Gonzalez. “Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric Approval.” Clin Ther 38, no. 9 (September 2016): 1995–2005. https://doi.org/10.1016/j.clinthera.2016.06.003.Full Text Link to Item
-
Romaine, Andrew, Daniel Ye, Zachary Ao, Francia Fang, Octavious Johnson, Taylor Blake, Daniel K. Benjamin, et al. “Safety of histamine-2 receptor blockers in hospitalized VLBW infants.” Early Hum Dev 99 (August 2016): 27–30. https://doi.org/10.1016/j.earlhumdev.2016.05.010.Full Text Link to Item
-
Gonzalez, Daniel, Paula Delmore, Barry T. Bloom, C Michael Cotten, Brenda B. Poindexter, Elisabeth McGowan, Karen Shattuck, et al. “Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants.” Antimicrob Agents Chemother 60, no. 5 (May 2016): 2888–94. https://doi.org/10.1128/AAC.03086-15.Full Text Link to Item
-
Gonzalez, Daniel, Debra L. Palazzi, Leena Bhattacharya-Mithal, Amira Al-Uzri, Laura P. James, John Bradley, Natalie Neu, et al. “Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents.” Antimicrob Agents Chemother 60, no. 4 (April 2016): 2572–76. https://doi.org/10.1128/AAC.02561-15.Full Text Link to Item
-
Ericson, Jessica E., Victor O. Popoola, P Brian Smith, Daniel K. Benjamin, Vance G. Fowler, Reese H. Clark, and Aaron M. Milstone. “Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.” Jama Pediatr 169, no. 12 (December 2015): 1105–11. https://doi.org/10.1001/jamapediatrics.2015.2380.Full Text Link to Item
-
Kelly, Matthew S., Daniel K. Benjamin, Karen M. Puopolo, Matthew M. Laughon, Reese H. Clark, Sagori Mukhopadhyay, P Brian Smith, and Sallie R. Permar. “Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary Dysplasia.” Jama Pediatr 169, no. 12 (December 2015): e153785. https://doi.org/10.1001/jamapediatrics.2015.3785.Full Text Link to Item
-
Thaden, Joshua T., Jessica E. Ericson, Heather Cross, Stephen P. Bergin, Julia A. Messina, Vance G. Fowler, Daniel K. Benjamin, et al. “Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants.” Pediatr Infect Dis J 34, no. 11 (November 2015): 1175–79. https://doi.org/10.1097/INF.0000000000000850.Full Text Link to Item
-
Arnold, Christopher J., Jessica Ericson, Nathan Cho, James Tian, Shelby Wilson, Vivian H. Chu, Christoph P. Hornik, et al. “Cefepime and Ceftazidime Safety in Hospitalized Infants.” Pediatr Infect Dis J 34, no. 9 (September 2015): 964–68. https://doi.org/10.1097/INF.0000000000000778.Full Text Link to Item
-
Bergin, Stephen P., Joshua T. Thaden, Jessica E. Ericson, Heather Cross, Julia Messina, Reese H. Clark, Vance G. Fowler, et al. “Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.” Pediatr Infect Dis J 34, no. 9 (September 2015): 933–36. https://doi.org/10.1097/INF.0000000000000769.Full Text Link to Item
-
Ericson, Jessica E., Christopher Arnold, Jomani Cheeseman, Jordan Cho, Sarah Kaneko, Ele’na Wilson, Reese H. Clark, et al. “Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.” J Pediatr Gastroenterol Nutr 61, no. 3 (September 2015): 334–39. https://doi.org/10.1097/MPG.0000000000000792.Full Text Link to Item
-
Offringa, Martin, Jonathan M. Davis, Mark A. Turner, Robert Ward, Ralph Bax, Sam Maldonado, Vikram Sinha, et al. “Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014.” Ther Innov Regul Sci 49, no. 5 (September 2015): 623–31. https://doi.org/10.1177/2168479015597730.Full Text Link to Item
-
Rowe, Stevie, David Siegel, Daniel K. Benjamin, and Daniel K. Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee. “Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care Medications.” Clin Ther 37, no. 9 (September 1, 2015): 1924–32. https://doi.org/10.1016/j.clinthera.2015.08.006.Full Text Link to Item
-
Harskamp-van Ginkel, Margreet W., Kevin D. Hill, Kristian C. Becker, Daniela Testoni, Michael Cohen-Wolkowiez, Daniel Gonzalez, Jeffrey S. Barrett, et al. “Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.” Jama Pediatr 169, no. 7 (July 2015): 678–85. https://doi.org/10.1001/jamapediatrics.2015.132.Full Text Link to Item
-
Watt, Kevin M., Daniel Gonzalez, Daniel K. Benjamin, Kim L. R. Brouwer, Kelly C. Wade, Edmund Capparelli, Jeffrey Barrett, and Michael Cohen-Wolkowiez. “Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation.” Antimicrob Agents Chemother 59, no. 7 (July 2015): 3935–43. https://doi.org/10.1128/AAC.00102-15.Full Text Link to Item
-
Arnold, Christopher J., Jessica Ericson, Jordan Kohman, Kaitlyn L. Corey, Morgan Oh, Janet Onabanjo, Christoph P. Hornik, et al. “Rifampin use and safety in hospitalized infants.” Am J Perinatol 32, no. 6 (May 2015): 565–70. https://doi.org/10.1055/s-0034-1543955.Full Text Link to Item
-
Botero-Calderon, Lorena, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Advances in the treatment of invasive neonatal candidiasis.” Expert Opin Pharmacother 16, no. 7 (May 2015): 1035–48. https://doi.org/10.1517/14656566.2015.1031108.Full Text Link to Item
-
Camelo Castillo, Wendy, Kim Boggess, Til Stürmer, M Alan Brookhart, Daniel K. Benjamin, and Michele Jonsson Funk. “Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes.” Jama Pediatr 169, no. 5 (May 2015): 452–58. https://doi.org/10.1001/jamapediatrics.2015.74.Full Text Link to Item
-
Johnson, Jason N., Christoph P. Hornik, Jennifer S. Li, Daniel K. Benjamin, Terry Yoshizumi, Robert E. Reiman, Donald P. Frush, and Kevin D. Hill. “Response to letters regarding article, "Cumulative radiation exposure and cancer risk estimation in children with heart disease".” Circulation 131, no. 16 (April 21, 2015): e419–20. https://doi.org/10.1161/CIRCULATIONAHA.114.013266.Full Text Link to Item
-
Ericson, Jessica E., Joshua Thaden, Heather R. Cross, Reese H. Clark, Vance G. Fowler, Daniel K. Benjamin, Michael Cohen-Wolkowiez, Christoph P. Hornik, P Brian Smith, and P Brian Antibacterial Resistance Leadership Group. “No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants.” Pediatr Infect Dis J 34, no. 4 (April 2015): 371–75. https://doi.org/10.1097/INF.0000000000000573.Full Text Link to Item
-
Kelly, Matthew S., Daniel K. Benjamin, and P Brian Smith. “The epidemiology and diagnosis of invasive candidiasis among premature infants.” Clin Perinatol 42, no. 1 (March 2015): 105–ix. https://doi.org/10.1016/j.clp.2014.10.008.Full Text Link to Item
-
Smith, P Brian, and Daniel K. Benjamin. “Neonatal-perinatal infections: an update.” Clin Perinatol 42, no. 1 (March 2015): xix–xx. https://doi.org/10.1016/j.clp.2014.12.001.Full Text Link to Item
-
Hope, William W., Atsunori Kaibara, Michael Roy, Antonio Arrieta, Nkechi Azie, Laura L. Kovanda, and Daniel K. Benjamin. “Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents.” Antimicrob Agents Chemother 59, no. 2 (February 2015): 905–13. https://doi.org/10.1128/AAC.03736-14.Full Text Link to Item
-
Autmizguine, Julie, Christoph P. Hornik, Daniel K. Benjamin, Matthew M. Laughon, Reese H. Clark, C Michael Cotten, Michael Cohen-Wolkowiez, P Brian Smith, and P Brian Best Pharmaceuticals for Children Act—Pediatric Trials Network Administrative Core Committee. “Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infants.” Pediatrics 135, no. 1 (January 2015): e117–25. https://doi.org/10.1542/peds.2014-2141.Full Text Link to Item
-
Gonzalez, Daniel, Chiara Melloni, Brenda B. Poindexter, Ram Yogev, Andrew M. Atz, Janice E. Sullivan, Susan R. Mendley, et al. “Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots.” Bioanalysis 7, no. 9 (2015): 1137–49. https://doi.org/10.4155/bio.15.38.Full Text Link to Item
-
Samiee-Zafarghandy, Samira, Sudha R. Raman, John N. van den Anker, Kerstin McHutchison, Christoph P. Hornik, Reese H. Clark, P. Brian Smith, and P. Best Pharmaceuticals for Children Act—Pediatric Trials Network Administrative Core Committee. “Safety of milrinone use in neonatal intensive care units.” Early Hum Dev 91, no. 1 (January 2015): 31–35. https://doi.org/10.1016/j.earlhumdev.2014.10.007.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, and Daniel K. Benjamin. “Editorial commentary: Fluconazole therapeutic drug monitoring in children with cancer: not today.” Clin Infect Dis 59, no. 11 (December 1, 2014): 1534–36. https://doi.org/10.1093/cid/ciu661.Full Text Link to Item
-
Benjamin, Daniel K. “Career Profile.” Clinical Pharmacology & Therapeutics 96, no. 4 (October 1, 2014): 411–411.Link to Item
-
Gonzalez, Daniel, Ian M. Paul, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Advances in pediatric pharmacology, therapeutics, and toxicology.” Adv Pediatr 61, no. 1 (August 2014): 7–31. https://doi.org/10.1016/j.yapd.2014.03.005.Full Text Link to Item
-
Laughon, Matthew M., and Daniel K. Benjamin. “Mechanisms to provide safe and effective drugs for children.” Pediatrics 134, no. 2 (August 2014): e562–63. https://doi.org/10.1542/peds.2014-1585.Full Text Link to Item
-
Autmizguine, Julie, Jeffrey T. Guptill, Michael Cohen-Wolkowiez, Daniel K. Benjamin, and Edmund V. Capparelli. “Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications.” Drugs 74, no. 8 (June 2014): 891–909. https://doi.org/10.1007/s40265-014-0227-3.Full Text Link to Item
-
Camelo Castillo, Wendy, Kim Boggess, Til Stürmer, M Alan Brookhart, Daniel K. Benjamin, and Michele Jonsson Funk. “Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011.” Obstet Gynecol 123, no. 6 (June 2014): 1177–84. https://doi.org/10.1097/AOG.0000000000000285.Full Text Link to Item
-
Tremoulet, Adriana, Jennifer Le, Brenda Poindexter, Janice E. Sullivan, Matthew Laughon, Paula Delmore, Andrea Salgado, et al. “Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.” Antimicrob Agents Chemother 58, no. 6 (June 2014): 3013–20. https://doi.org/10.1128/AAC.02374-13.Full Text Link to Item
-
Benjamin, Daniel K., Mark L. Hudak, Shahnaz Duara, David A. Randolph, Margarita Bidegain, Gratias T. Mundakel, Girija Natarajan, et al. “Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.” Jama 311, no. 17 (May 7, 2014): 1742–49. https://doi.org/10.1001/jama.2014.2624.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Kevin M. Watt, Chenguang Zhou, Barry T. Bloom, Brenda Poindexter, Lisa Castro, Jamie Gao, Edmund V. Capparelli, Daniel K. Benjamin, and P Brian Smith. “Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.” Antimicrob Agents Chemother 58, no. 5 (May 2014): 2856–65. https://doi.org/10.1128/AAC.02139-13.Full Text Link to Item
-
Beam, Kristyn S., Matthew M. Laughon, Christoph P. Hornik, Michael Cohen-Wolkowiez, Reese H. Clark, Daniel K. Benjamin, and P Brian Smith. “Predictors of positive cerebrospinal fluid cultures in infants with bacteremia.” Pediatr Infect Dis J 33, no. 4 (April 2014): 360–65. https://doi.org/10.1097/INF.0000000000000115.Full Text Link to Item
-
Ericson, Jessica E., and Daniel K. Benjamin. “Fluconazole prophylaxis for prevention of invasive candidiasis in infants.” Curr Opin Pediatr 26, no. 2 (April 2014): 151–56. https://doi.org/10.1097/MOP.0000000000000060.Full Text Link to Item
-
Aliaga, Sofia, Reese H. Clark, Matthew Laughon, Thomas J. Walsh, William W. Hope, Daniel K. Benjamin, David Kaufman, Antonio Arrieta, and P Brian Smith. “Changes in the incidence of candidiasis in neonatal intensive care units.” Pediatrics 133, no. 2 (February 2014): 236–42. https://doi.org/10.1542/peds.2013-0671.Full Text Link to Item
-
Autmizguine, Julie, Daniel K. Benjamin, P Brian Smith, Mario Sampson, Philippe Ovetchkine, Michael Cohen-Wolkowiez, and Kevin M. Watt. “Pharmacokinetic studies in infants using minimal-risk study designs.” Curr Clin Pharmacol 9, no. 4 (2014): 350–58. https://doi.org/10.2174/1574884709666140520153308.Full Text Link to Item
-
Sampson, M. R., B. T. Bloom, A. Arrieta, E. Capparelli, D. K. Benjamin, P. B. Smith, G. L. Kearns, J. van den Anker, and M. Cohen-Wolkowiez. “Intestinal fatty-acid binding protein and metronidazole response in premature infants.” J Neonatal Perinatal Med 7, no. 3 (January 1, 2014): 223–28. https://doi.org/10.3233/NPM-1477013.Full Text Link to Item
-
Castillo, Wendy Camelo, Kim Boggess, Til Sturmer, M Alan Brookhart, and Daniel K. Benjamin. “Use of Glyburide vs. Insulin for Treatment of Gestational Diabetes in the US, 2000-2010.” Pharmacoepidemiology and Drug Safety 22 (October 1, 2013): 145–145.Link to Item
-
Sampson, M. R., B. T. Bloom, R. W. Lenfestey, B. Harper, A. D. Kashuba, R. Anand, D. K. Benjamin, E. Capparelli, M. Cohen-Wolkowiez, and P. B. Smith. “Population Pharmacokinetics of Intravenous Acyclovir in Preterm and Term Infants.” Pediatr Infect Dis J, September 23, 2013. https://doi.org/10.1097/01.inf.0000434359.14847.80.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Mario Sampson, Barry T. Bloom, Antonio Arrieta, James L. Wynn, Karen Martz, Barrie Harper, et al. “Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants.” Pediatr Infect Dis J 32, no. 9 (September 2013): 956–61. https://doi.org/10.1097/INF.0b013e3182947cf8.Full Text Link to Item
-
Hill, Kevin D., Robert D. Tunks, Piers C. A. Barker, Daniel K. Benjamin, Michael Cohen-Wolkowiez, Gregory A. Fleming, Matthew Laughon, and Jennifer S. Li. “Sildenafil exposure and hemodynamic effect after stage II single-ventricle surgery.” Pediatr Crit Care Med 14, no. 6 (July 2013): 593–600. https://doi.org/10.1097/PCC.0b013e31828aa5ee.Full Text Link to Item
-
Hornik, Christoph P., Amy H. Herring, Daniel K. Benjamin, Edmund V. Capparelli, Gregory L. Kearns, John van den Anker, Michael Cohen-Wolkowiez, Reese H. Clark, P Brian Smith, and P Brian Best Pharmaceuticals for Children Act-Pediatric Trials Network. “Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants.” Pediatr Infect Dis J 32, no. 7 (July 2013): 748–53. https://doi.org/10.1097/INF.0b013e31828be70b.Full Text Link to Item
-
Boucher, Helen W., George H. Talbot, Daniel K. Benjamin, John Bradley, Robert J. Guidos, Ronald N. Jones, Barbara E. Murray, Robert A. Bonomo, David Gilbert, and David Infectious Diseases Society of America. “10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.” Clin Infect Dis 56, no. 12 (June 2013): 1685–94. https://doi.org/10.1093/cid/cit152.Full Text Link to Item
-
Buzzi, Eleonora, Paolo Manzoni, Elio Castagnola, Daniel K. Benjamin, Renzo Beghini, and Alberto Dall’agnola. “Candida pneumonia in a term infant after prolonged use of inhaled corticosteroids for bronchopulmonary dysplasia (BPD).” Early Hum Dev 89 Suppl 1 (June 2013): S62–63. https://doi.org/10.1016/S0378-3782(13)70018-5.Full Text Link to Item
-
Ericson, Jessica, Paolo Manzoni, and Daniel K. Benjamin. “Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.” Early Hum Dev 89 Suppl 1, no. 0 1 (June 2013): S25–27. https://doi.org/10.1016/S0378-3782(13)70009-4.Full Text Link to Item
-
Lestner, Jodi M., P Brian Smith, Michael Cohen-Wolkowiez, Daniel K. Benjamin, and William W. Hope. “Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective.” Br J Clin Pharmacol 75, no. 6 (June 2013): 1381–95. https://doi.org/10.1111/bcp.12025.Full Text Link to Item
-
Picone, Simonetta, Paolo Manzoni, Manuela Bedetta, Michael Mostert, Daniel K. Benjamin, and Piermichele Paolillo. “Pharmacological resolution of a multiloculated Candida spp. liver abscess in a preterm neonate.” Early Hum Dev 89 Suppl 1 (June 2013): S47–50. https://doi.org/10.1016/S0378-3782(13)70015-X.Full Text Link to Item
-
Manzoni, Paolo, Daniel K. Benjamin, Caterina Franco, Stefano Rizzollo, Mauro Stronati, Kevin Watt, Michael Cohen-Wolkowiez, and Evelyne Jacqz-Aigrain. “Echinocandins for the nursery: an update.” Curr Drug Metab 14, no. 2 (February 2013): 203–7.Link to Item
-
Watt, Kevin, Paolo Manzoni, Michael Cohen-Wolkowiez, Stefano Rizzollo, Elena Boano, Evelyne Jacqz-Aigrain, and Daniel K. Benjamin. “Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.” Curr Drug Metab 14, no. 2 (February 2013): 193–202.Link to Item
-
Sampson, Mr, M. Cohen-Wolkowiez, Dk Benjamin, Ev Capparelli, and Km Watt. “Pharmacokinetics of Antimicrobials in Obese Children.” Gabi J 2, no. 2 (2013): 76–81. https://doi.org/10.5639/gabij.2013.0202.025.Full Text Link to Item
-
Testoni, Daniela, Christoph P. Hornik, P Brian Smith, Daniel K. Benjamin, and Ross E. McKinney. “Sports medicine and ethics.” Am J Bioeth 13, no. 10 (2013): 4–12. https://doi.org/10.1080/15265161.2013.828114.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Brenda Poindexter, Margarita Bidegain, Joern-Hendrik Weitkamp, Robert L. Schelonka, David A. Randolph, Robert M. Ward, et al. “Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.” Clin Infect Dis 55, no. 11 (December 2012): 1495–1502. https://doi.org/10.1093/cid/cis758.Full Text Link to Item
-
Steinbach, William J., Emmanuel Roilides, David Berman, Jill A. Hoffman, Andreas H. Groll, Ibrahim Bin-Hussain, Debra L. Palazzi, et al. “Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.” Pediatr Infect Dis J 31, no. 12 (December 2012): 1252–57. https://doi.org/10.1097/INF.0b013e3182737427.Full Text Link to Item
-
Tripathi, Nidhi, Kevin Watt, and Daniel K. Benjamin. “Treatment and prophylaxis of invasive candidiasis.” Semin Perinatol 36, no. 6 (December 2012): 416–23. https://doi.org/10.1053/j.semperi.2012.06.003.Full Text Link to Item
-
Lin, Cheryl B., Christoph P. Hornik, Reese Clark, C Michael Cotten, Daniel K. Benjamin, Michael Cohen-Wolkoweiz, P Brian Smith, and James L. Wynn. “Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis.” Early Hum Dev 88, no. 11 (November 2012): 905–9. https://doi.org/10.1016/j.earlhumdev.2012.07.009.Full Text Link to Item
-
Cotten, C Michael, Daniel K. Benjamin, P Brian Smith, Barbara J. Stoll, Alan R. Spitzer, and Reese H. Clark. “Empirical antibiotic therapy for suspected early-onset bacterial sepsis.” Pediatrics 130, no. 4 (October 2012): e1052–53. https://doi.org/10.1542/peds.2012-2302A.Full Text Link to Item
-
Infectious Diseases Society of America, Bernard. “White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens.” Clin Infect Dis 55, no. 8 (October 2012): 1031–46. https://doi.org/10.1093/cid/cis688.Full Text Link to Item
-
Watt, Kevin M., Daniel K. Benjamin, Ira M. Cheifetz, Ganesh Moorthy, Kelly C. Wade, P Brian Smith, Kim L. R. Brouwer, Edmund V. Capparelli, and Michael Cohen-Wolkowiez. “Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation.” Pediatr Infect Dis J 31, no. 10 (October 2012): 1042–47. https://doi.org/10.1097/INF.0b013e31825d3091.Full Text Link to Item
-
Bliss, Joseph M., Angela Y. Wong, Grace Bhak, Sonia S. Laforce-Nesbitt, Sarah Taylor, Sylvia Tan, Barbara J. Stoll, et al. “Candida virulence properties and adverse clinical outcomes in neonatal candidiasis.” J Pediatr 161, no. 3 (September 2012): 441-447.e2. https://doi.org/10.1016/j.jpeds.2012.02.051.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Kevin M. Watt, Christoph P. Hornik, Daniel K. Benjamin, and P Brian Smith. “Pharmacokinetics and tolerability of single-dose daptomycin in young infants.” Pediatr Infect Dis J 31, no. 9 (September 2012): 935–37. https://doi.org/10.1097/INF.0b013e31825d2fa2.Full Text Link to Item
-
Sampson, Mario R., Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Evidence-based guidelines for pediatric clinical trials: focus on StaR Child Health.” Expert Rev Clin Pharmacol 5, no. 5 (September 2012): 525–31. https://doi.org/10.1586/ecp.12.52.Full Text Link to Item
-
Schell, W. A., J. L. Benton, P. B. Smith, M. Poore, J. L. Rouse, D. J. Boles, M. D. Johnson, et al. “Evaluation of a digital microfluidic real-time PCR platform to detect DNA of Candida albicans in blood.” Eur J Clin Microbiol Infect Dis 31, no. 9 (September 2012): 2237–45. https://doi.org/10.1007/s10096-012-1561-6.Full Text Open Access Copy Link to Item
-
Greenberg, Rachel G., Daniel K. Benjamin, Marie G. Gantz, C Michael Cotten, Barbara J. Stoll, Michele C. Walsh, Pablo J. Sánchez, et al. “Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis.” J Pediatr 161, no. 2 (August 2012): 264-9.e2. https://doi.org/10.1016/j.jpeds.2012.01.053.Full Text Link to Item
-
Hornik, Christoph P., Daniel K. Benjamin, Kristian C. Becker, Jennifer Li, Reese H. Clark, Michael Cohen-Wolkowiez, and P Brian Smith. “Use of the complete blood cell count in early-onset neonatal sepsis.” Pediatr Infect Dis J 31, no. 8 (August 2012): 799–802. https://doi.org/10.1097/INF.0b013e318256905c.Full Text Link to Item
-
Hornik, Christoph P., Daniel K. Benjamin, Kristian C. Becker, Jennifer Li, Reese H. Clark, Michael Cohen-Wolkowiez, and P Brian Smith. “Use of the complete blood cell count in late-onset neonatal sepsis.” Pediatr Infect Dis J 31, no. 8 (August 2012): 803–7. https://doi.org/10.1097/INF.0b013e31825691e4.Full Text Link to Item
-
Sood, Beena G., Seetha Shankaran, Robert L. Schelonka, Shampa Saha, Danny K. Benjamin, Pablo J. Sánchez, Ira Adams-Chapman, et al. “Cytokine profiles of preterm neonates with fungal and bacterial sepsis.” Pediatr Res 72, no. 2 (August 2012): 212–20. https://doi.org/10.1038/pr.2012.56.Full Text Open Access Copy Link to Item
-
Cohen-Wolkowiez, Michael, Daniel K. Benjamin, Ashley Ross, Laura P. James, Janice E. Sullivan, Michele C. Walsh, Arlene Zadell, et al. “Population pharmacokinetics of piperacillin using scavenged samples from preterm infants.” Ther Drug Monit 34, no. 3 (June 2012): 312–19. https://doi.org/10.1097/FTD.0b013e3182587665.Full Text Link to Item
-
Doby, Elizabeth H., Daniel K. Benjamin, Anne J. Blaschke, Robert M. Ward, Andrew T. Pavia, Paul L. Martin, Timothy A. Driscoll, Michael Cohen-Wolkowiez, and Cassandra Moran. “Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.” Pediatr Infect Dis J 31, no. 6 (June 2012): 632–35. https://doi.org/10.1097/INF.0b013e31824acc33.Full Text Link to Item
-
Watt, Kevin M., Michael Cohen-Wolkowiez, Robert M. Ward, and Daniel K. Benjamin. “Commentary: pediatric antifungal drug development: lessons learned and recommendations for the future.” Pediatr Infect Dis J 31, no. 6 (June 2012): 635–37. https://doi.org/10.1097/INF.0b013e31824f8426.Full Text Link to Item
-
Ascher, S. B., P. B. Smith, R. H. Clark, M. Cohen-Wolkowiez, J. S. Li, K. Watt, E. Jacqz-Aigrain, F. Kaguelidou, P. Manzoni, and D. K. Benjamin. “Sepsis in young infants with congenital heart disease.” Early Hum Dev 88 Suppl 2, no. Suppl 2 (May 2012): S92–97. https://doi.org/10.1016/S0378-3782(12)70025-7.Full Text Link to Item
-
Ascher, Simon B., P Brian Smith, Kevin Watt, Daniel K. Benjamin, Michael Cohen-Wolkowiez, Reese H. Clark, and Cassandra Moran. “Antifungal therapy and outcomes in infants with invasive Candida infections.” Pediatr Infect Dis J 31, no. 5 (May 2012): 439–43. https://doi.org/10.1097/INF.0b013e3182467a72.Full Text Link to Item
-
Hornik, C. P., P. Fort, R. H. Clark, K. Watt, D. K. Benjamin, P. B. Smith, P. Manzoni, E. Jacqz-Aigrain, F. Kaguelidou, and M. Cohen-Wolkowiez. “Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units.” Early Hum Dev 88 Suppl 2, no. Suppl 2 (May 2012): S69–74. https://doi.org/10.1016/S0378-3782(12)70019-1.Full Text Link to Item
-
Hsieh, E., P. B. Smith, E. Jacqz-Aigrain, F. Kaguelidou, M. Cohen-Wolkowiez, P. Manzoni, and D. K. Benjamin. “Neonatal fungal infections: when to treat?” Early Hum Dev 88 Suppl 2, no. Suppl 2 (May 2012): S6–10. https://doi.org/10.1016/S0378-3782(12)70004-X.Full Text Link to Item
-
Manzoni, P., M. Mostert, M. A. Latino, L. Pugni, I. Stolfi, L. Decembrino, F. Vagnarelli, et al. “Clinical characteristics and response to prophylactic fluconazole of preterm VLBW neonates with baseline and acquired fungal colonisation in NICU: data from a multicentre RCT.” Early Hum Dev 88 Suppl 2 (May 2012): S60–64. https://doi.org/10.1016/S0378-3782(12)70017-8.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Daniele Ouellet, P Brian Smith, Laura P. James, Ashley Ross, Janice E. Sullivan, Michele C. Walsh, et al. “Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants.” Antimicrob Agents Chemother 56, no. 4 (April 2012): 1828–37. https://doi.org/10.1128/AAC.06071-11.Full Text Link to Item
-
Wynn, James L., Daniel K. Benjamin, Michael Cohen-Wolkowiez, Reese H. Clark, and P Brian Smith. “Very late onset infections in the neonatal intensive care unit.” Early Hum Dev 88, no. 4 (April 2012): 217–25. https://doi.org/10.1016/j.earlhumdev.2011.08.009.Full Text Link to Item
-
Testoni, Daniela, P Brian Smith, and Daniel K. Benjamin. “The use of antifungal therapy in neonatal intensive care.” Clin Perinatol 39, no. 1 (March 2012): 83–98. https://doi.org/10.1016/j.clp.2011.12.008.Full Text Link to Item
-
Warn, Peter A., Joanne Livermore, Susan Howard, Timothy W. Felton, Andrew Sharp, Lea Gregson, Joanne Goodwin, et al. “Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach.” Antimicrob Agents Chemother 56, no. 2 (February 2012): 708–14. https://doi.org/10.1128/AAC.05826-11.Full Text Link to Item
-
Watt, Kevin M., Matthew M. Massaro, Brian Smith, Michael Cohen-Wolkowiez, Daniel K. Benjamin, and Matthew M. Laughon. “Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.” Pediatr Infect Dis J 31, no. 2 (February 2012): 197–99. https://doi.org/10.1097/INF.0b013e31823980c3.Full Text Link to Item
-
Wynn, James L., Sylvia Tan, Marie G. Gantz, Abhik Das, Ronald N. Goldberg, Ira Adams-Chapman, Barbara J. Stoll, et al. “Outcomes following candiduria in extremely low birth weight infants.” Clin Infect Dis 54, no. 3 (February 1, 2012): 331–39. https://doi.org/10.1093/cid/cir800.Full Text Link to Item
-
Turner, K., P. Manzoni, D. K. Benjamin, M. Cohen-Wolkowiez, P. B. Smith, and M. M. Laughon. “Fluconazole pharmacokinetics and safety in premature infants.” Curr Med Chem 19, no. 27 (2012): 4617–20. https://doi.org/10.2174/092986712803306367.Full Text Link to Item
-
Wade, K. C., and D. K. Benjamin. “Clinical Pharmacology of Anti-Infective Drugs,” December 1, 2011, 1160–1211. https://doi.org/10.1016/B978-1-4160-6400-8.00037-7.Full Text
-
Cohen-Wolkowiez, Michael, Nicole R. White, Arlene Bridges, Daniel K. Benjamin, and Angela D. M. Kashuba. “Development of a liquid chromatography-tandem mass spectrometry assay of six antimicrobials in plasma for pharmacokinetic studies in premature infants.” J Chromatogr B Analyt Technol Biomed Life Sci 879, no. 30 (November 15, 2011): 3497–3506. https://doi.org/10.1016/j.jchromb.2011.09.031.Full Text Link to Item
-
Smith, P Brian, Michael Cohen-Wolkowiez, Lisa M. Castro, Brenda Poindexter, Margarita Bidegain, Joern-Hendrik Weitkamp, Robert L. Schelonka, et al. “Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections.” Pediatr Infect Dis J 30, no. 10 (October 2011): 844–49. https://doi.org/10.1097/INF.0b013e31822e8b0b.Full Text Link to Item
-
Laughon, Matthew M., Daniel K. Benjamin, Edmund V. Capparelli, Gregory L. Kearns, Katherine Berezny, Ian M. Paul, Kelly Wade, Jeff Barrett, Phillip Brian Smith, and Michael Cohen-Wolkowiez. “Innovative clinical trial design for pediatric therapeutics.” Expert Rev Clin Pharmacol 4, no. 5 (September 2011): 643–52. https://doi.org/10.1586/ecp.11.43.Full Text Link to Item
-
Watt, Kevin, Jennifer S. Li, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenation.” J Cardiovasc Pharmacol 58, no. 2 (August 2011): 126–32. https://doi.org/10.1097/FJC.0b013e318213aac2.Full Text Link to Item
-
Jean-Baptiste, Naomi, Daniel K. Benjamin, Michael Cohen-Wolkowiez, Vance G. Fowler, Matthew Laughon, Reese H. Clark, and P Brian Smith. “Coagulase-negative staphylococcal infections in the neonatal intensive care unit.” Infect Control Hosp Epidemiol 32, no. 7 (July 2011): 679–86. https://doi.org/10.1086/660361.Full Text Link to Item
-
Greenberg, R. G., D. K. Benjamin, M. Cohen-Wolkowiez, R. H. Clark, C. M. Cotten, M. Laughon, and P. B. Smith. “Repeat lumbar punctures in infants with meningitis in the neonatal intensive care unit.” J Perinatol 31, no. 6 (June 2011): 425–29. https://doi.org/10.1038/jp.2010.142.Full Text Link to Item
-
Cohen-Wolkowiez, M., D. K. Benjamin, L. Piper, I. M. Cheifetz, C. Moran, P. Liu, J. Aram, et al. “Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates.” Clin Pharmacol Ther 89, no. 5 (May 2011): 702–7. https://doi.org/10.1038/clpt.2011.26.Full Text Link to Item
-
Piper, Lauren, P Brian Smith, Christoph P. Hornik, Ira M. Cheifetz, Jeffrey S. Barrett, Ganesh Moorthy, William W. Hope, Kelly C. Wade, Michael Cohen-Wolkowiez, and Daniel K. Benjamin. “Fluconazole loading dose pharmacokinetics and safety in infants.” Pediatr Infect Dis J 30, no. 5 (May 2011): 375–78. https://doi.org/10.1097/INF.0b013e318202cbb3.Full Text Link to Item
-
Wallace, Michelle C., James Jaggers, Jennifer S. Li, Marshall L. Jacobs, Jeffrey P. Jacobs, Daniel K. Benjamin, Sean M. O’Brien, Eric D. Peterson, P Brian Smith, and Sara K. Pasquali. “Center variation in patient age and weight at Fontan operation and impact on postoperative outcomes.” Ann Thorac Surg 91, no. 5 (May 2011): 1445–52. https://doi.org/10.1016/j.athoracsur.2010.11.064.Full Text Link to Item
-
Yanni, Souzan B., P Brian Smith, Daniel K. Benjamin, Patrick F. Augustijns, Dhiren R. Thakker, and Pieter P. Annaert. “Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding.” Biopharm Drug Dispos 32, no. 4 (May 2011): 222–32. https://doi.org/10.1002/bdd.752.Full Text Link to Item
-
Ascher, Simon, Phillip Brian Smith, and Daniel K. Benjamin. “Safety of micafungin in infants: insights into optimal dosing.” Expert Opin Drug Saf 10, no. 2 (March 2011): 281–86. https://doi.org/10.1517/14740338.2011.545345.Full Text Link to Item
-
Watt, Kevin, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Pharmacokinetics of antifungal agents in children.” Early Hum Dev 87 Suppl 1 (March 2011): S61–65. https://doi.org/10.1016/j.earlhumdev.2011.01.014.Full Text Link to Item
-
Pasquali, S. K., D. S. Burstein, D. K. Benjamin, P. B. Smith, and J. S. Li. “In reply.” Pediatrics 127, no. 1 (January 1, 2011). https://doi.org/10.1542/peds.2010-3381B.Full Text
-
Smith, P Brian, and Daniel K. Benjamin. “Choosing the right empirical antibiotics for neonates.” Arch Dis Child Fetal Neonatal Ed 96, no. 1 (January 2011): F2–3. https://doi.org/10.1136/adc.2010.188938.Full Text Link to Item
-
Benjamin, Daniel K., Barbara J. Stoll, Marie G. Gantz, Michele C. Walsh, Pablo J. Sánchez, Abhik Das, Seetha Shankaran, et al. “Neonatal candidiasis: epidemiology, risk factors, and clinical judgment.” Pediatrics 126, no. 4 (October 2010): e865–73. https://doi.org/10.1542/peds.2009-3412.Full Text Link to Item
-
Manzoni, Paolo, Stefano Rizzollo, Caterina Franco, Elena Gallo, Paolo Galletto, Elena Boano, Michael Mostert, Daniel K. Benjamin, Evelyne Jacqz-Aigrain, and Daniele Farina. “Role of echinocandins in the management of fungal infections in neonates.” J Matern Fetal Neonatal Med 23 Suppl 3 (October 2010): 49–52. https://doi.org/10.3109/14767058.2010.509914.Full Text Link to Item
-
Yanni, Souzan B., Patrick F. Augustijns, Daniel K. Benjamin, Kim L. R. Brouwer, Dhiren R. Thakker, and Pieter P. Annaert. “In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.” Drug Metab Dispos 38, no. 10 (October 2010): 1848–56. https://doi.org/10.1124/dmd.110.033811.Full Text Link to Item
-
Pasquali, Sara K., Danielle S. Burstein, Daniel K. Benjamin, P Brian Smith, and Jennifer S. Li. “Globalization of pediatric research: analysis of clinical trials completed for pediatric exclusivity.” Pediatrics 126, no. 3 (September 2010): e687–92. https://doi.org/10.1542/peds.2010-0098.Full Text Link to Item
-
Downey, L Corbin, P Brian Smith, and Daniel K. Benjamin. “Risk factors and prevention of late-onset sepsis in premature infants.” Early Hum Dev 86 Suppl 1, no. Suppl 1 (July 2010): 7–12. https://doi.org/10.1016/j.earlhumdev.2010.01.012.Full Text Link to Item
-
Baker-Smith, C. M., D. K. Benjamin, R. M. Califf, M. D. Murphy, J. S. Li, and P. B. Smith. “Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials.” Clin Pharmacol Ther 87, no. 6 (June 2010): 668–71. https://doi.org/10.1038/clpt.2009.231.Full Text Link to Item
-
Hope, William W., P Brian Smith, Antonio Arrieta, Donald N. Buell, Michael Roy, Atsunori Kaibara, Thomas J. Walsh, Michael Cohen-Wolkowiez, and Daniel K. Benjamin. “Population pharmacokinetics of micafungin in neonates and young infants.” Antimicrob Agents Chemother 54, no. 6 (June 2010): 2633–37. https://doi.org/10.1128/AAC.01679-09.Full Text Link to Item
-
Li, J. S., D. K. Benjamin, R. J. Portman, and T. Severin. “Paediatric anti-hypertensive clinical trials and various factors influencing trial success or failure,” May 21, 2010, 196–205. https://doi.org/10.1159/B978-380559363-2.31559-1.Full Text
-
Greenberg, Rachel G., Cassandra Moran, Martin Ulshen, P Brian Smith, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Outcomes of catheter-associated infections in pediatric patients with short bowel syndrome.” J Pediatr Gastroenterol Nutr 50, no. 4 (April 2010): 460–62. https://doi.org/10.1097/MPG.0b013e3181b99d07.Full Text Link to Item
-
Kehl-Fie, Thomas E., Eric A. Porsch, Pablo Yagupsky, Elizabeth A. Grass, Caroline Obert, Daniel K. Benjamin, and Joseph W. St Geme. “Examination of type IV pilus expression and pilus-associated phenotypes in Kingella kingae clinical isolates.” Infect Immun 78, no. 4 (April 2010): 1692–99. https://doi.org/10.1128/IAI.00908-09.Full Text Link to Item
-
Nowell, L., C. Moran, P. B. Smith, P. Seed, B. D. Alexander, C. M. Cotten, J. S. Wiener, and D. K. Benjamin. “Prevalence of renal anomalies after urinary tract infections in hospitalized infants less than 2 months of age.” J Perinatol 30, no. 4 (April 2010): 281–85. https://doi.org/10.1038/jp.2009.147.Full Text Open Access Copy Link to Item
-
Barker, Gregory M., Sean M. O’Brien, Karl F. Welke, Marshall L. Jacobs, Jeffrey P. Jacobs, Daniel K. Benjamin, Eric D. Peterson, James Jaggers, and Jennifer S. Li. “Major infection after pediatric cardiac surgery: a risk estimation model.” Ann Thorac Surg 89, no. 3 (March 2010): 843–50. https://doi.org/10.1016/j.athoracsur.2009.11.048.Full Text Link to Item
-
Downey, L Corbin, P Brian Smith, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Recent Advances in the Detection of Neonatal Candidiasis.” Curr Fungal Infect Rep 4, no. 1 (March 1, 2010): 17–22. https://doi.org/10.1007/s12281-010-0002-1.Full Text Link to Item
-
Moran, Cassandra, Chelsea A. Grussemeyer, James R. Spalding, Daniel K. Benjamin, and Shelby D. Reed. “Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections.” Am J Infect Control 38, no. 1 (February 2010): 78–80. https://doi.org/10.1016/j.ajic.2009.06.014.Full Text Link to Item
-
Benjamin, D. K., P. B. Smith, A. Arrieta, L. Castro, P. J. Sánchez, D. Kaufman, L. J. Arnold, et al. “Safety and pharmacokinetics of repeat-dose micafungin in young infants.” Clin Pharmacol Ther 87, no. 1 (January 2010): 93–99. https://doi.org/10.1038/clpt.2009.200.Full Text Link to Item
-
Kishnani, Priya S., Paula C. Goldenberg, Stephanie L. DeArmey, James Heller, Danny Benjamin, Sarah Young, Deeksha Bali, et al. “Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants.” Mol Genet Metab 99, no. 1 (January 2010): 26–33. https://doi.org/10.1016/j.ymgme.2009.08.003.Full Text Link to Item
-
Moran, Cassandra, and Danny Benjamin. “Treatment of neonatal fungal infections.” Adv Exp Med Biol 659 (2010): 129–38. https://doi.org/10.1007/978-1-4419-0981-7_11.Full Text Link to Item
-
Yanni, Souzan B., Pieter P. Annaert, Patrick Augustijns, Joseph G. Ibrahim, Daniel K. Benjamin, and Dhiren R. Thakker. “In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.” Drug Metab Dispos 38, no. 1 (January 2010): 25–31. https://doi.org/10.1124/dmd.109.029769.Full Text Link to Item
-
Benjamin, Daniel K., P Brian Smith, M Jessica M. Sun, M Dianne Murphy, Debbie Avant, Lisa Mathis, William Rodriguez, Robert M. Califf, and Jennifer S. Li. “Safety and transparency of pediatric drug trials.” Arch Pediatr Adolesc Med 163, no. 12 (December 2009): 1080–86. https://doi.org/10.1001/archpediatrics.2009.229.Full Text Link to Item
-
Cohen-Wolkowiez, M., D. K. Benjamin, and P. B. Smith. “Management of neonatal candidiasis.” Journal of Invasive Fungal Infections 3, no. 1 (December 1, 2009): 9–14.
-
Cohen-Wolkowiez, Michael, Cassandra Moran, Daniel K. Benjamin, C Michael Cotten, Reese H. Clark, and P Brian Smith. “Early and late onset sepsis in late preterm infants.” Pediatr Infect Dis J 28, no. 12 (December 2009): 1052–56. https://doi.org/10.1097/inf.0b013e3181acf6bd.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Cassandra Moran, Daniel K. Benjamin, and Phillip B. Smith. “Pediatric antifungal agents.” Curr Opin Infect Dis 22, no. 6 (December 2009): 553–58. https://doi.org/10.1097/QCO.0b013e3283321ccc.Full Text Link to Item
-
Moran, C., P. B. Smith, M. Cohen-Wolkowiez, and D. K. Benjamin. “Clinical trial design in neonatal pharmacology: effect of center differences, with lessons from the Pediatric Oncology Cooperative Research experience.” Clin Pharmacol Ther 86, no. 6 (December 2009): 589–91. https://doi.org/10.1038/clpt.2009.175.Full Text Link to Item
-
Ansong, Annette K., P Brian Smith, Daniel K. Benjamin, Reese H. Clark, Jennifer S. Li, C Michael Cotten, Barry Mangum, and Harmony P. Garges. “Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis.” Early Hum Dev 85, no. 10 Suppl (October 2009): S5–7. https://doi.org/10.1016/j.earlhumdev.2009.08.003.Full Text Link to Item
-
Roilides, Emmanuel, Theoklis E. Zaoutis, Aspasia Katragkou, Daniel K. Benjamin, and Thomas J. Walsh. “Zygomycosis in neonates: an uncommon but life-threatening infection.” Am J Perinatol 26, no. 8 (September 2009): 565–73. https://doi.org/10.1055/s-0029-1220775.Full Text Link to Item
-
Wade, Kelly C., Daniel K. Benjamin, David A. Kaufman, Robert M. Ward, Phillip B. Smith, Bhuvana Jayaraman, Peter C. Adamson, Marc R. Gastonguay, and Jeffrey S. Barrett. “Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.” Pediatr Infect Dis J 28, no. 8 (August 2009): 717–23. https://doi.org/10.1097/INF.0b013e31819f1f50.Full Text Link to Item
-
Johnson, Opemipo O., Daniel K. Benjamin, Werner Schimana, L Gayani Tillekeratne, John A. Crump, Keren Z. Landman, Grace D. Kinabo, et al. “Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.” Pediatr Infect Dis J 28, no. 6 (June 2009): 493–97. https://doi.org/10.1097/INF.0b013e3181950b7f.Full Text Link to Item
-
Moran, Cassandra, Chelsea A. Grussemeyer, James R. Spalding, Daniel K. Benjamin, and Shelby D. Reed. “Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs.” Pediatr Infect Dis J 28, no. 5 (May 2009): 433–35. https://doi.org/10.1097/INF.0b013e3181920ffd.Full Text Link to Item
-
Smith, P Brian, Thomas J. Walsh, William Hope, Antonio Arrieta, Akitsugu Takada, Laura L. Kovanda, Gregory L. Kearns, et al. “Pharmacokinetics of an elevated dosage of micafungin in premature neonates.” Pediatr Infect Dis J 28, no. 5 (May 2009): 412–15. https://doi.org/10.1097/INF.0b013e3181910e2d.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Daniel K. Benjamin, and Edmund Capparelli. “Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis.” Curr Opin Pediatr 21, no. 2 (April 2009): 177–81. https://doi.org/10.1097/MOP.0b013e32832925e5.Full Text Link to Item
-
Schultz, Eric D., David T. Tanaka, Ronald N. Goldberg, Daniel K. Benjamin, and P Brian Smith. “Effect of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit on total hospital cost.” Infect Control Hosp Epidemiol 30, no. 4 (April 2009): 383–85. https://doi.org/10.1086/596610.Full Text Link to Item
-
Pappas, Peter G., Carol A. Kauffman, David Andes, Daniel K. Benjamin, Thierry F. Calandra, John E. Edwards, Scott G. Filler, et al. “Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.” Clin Infect Dis 48, no. 5 (March 1, 2009): 503–35. https://doi.org/10.1086/596757.Full Text Link to Item
-
Stryjewski, Martin E., Zeina A. Kanafani, Vivian H. Chu, Paul A. Pappas, Tina Harding, Laura A. Drew, Daniel K. Benjamin, et al. “Staphylococcus aureus bacteremia among patients with health care-associated fever.” Am J Med 122, no. 3 (March 2009): 281-289.e2. https://doi.org/10.1016/j.amjmed.2008.09.040.Full Text Link to Item
-
Cotten, C Michael, Sarah Taylor, Barbara Stoll, Ronald N. Goldberg, Nellie I. Hansen, Pablo J. Sánchez, Namasivayam Ambalavanan, Daniel K. Benjamin, and Daniel K. NICHD Neonatal Research Network. “Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants.” Pediatrics 123, no. 1 (January 2009): 58–66. https://doi.org/10.1542/peds.2007-3423.Full Text Link to Item
-
Greenberg, Rachel G., P Brian Smith, C Michael Cotten, M Anthony Moody, Reese H. Clark, and Daniel K. Benjamin. “Traumatic lumbar punctures in neonates: test performance of the cerebrospinal fluid white blood cell count.” Pediatr Infect Dis J 27, no. 12 (December 2008): 1047–51. https://doi.org/10.1097/INF.0b013e31817e519b.Full Text Link to Item
-
Wade, K. C., D. Wu, D. A. Kaufman, R. M. Ward, D. K. Benjamin, J. E. Sullivan, N. Ramey, et al. “Population pharmacokinetics of fluconazole in young infants.” Antimicrob Agents Chemother 52, no. 11 (November 2008): 4043–49. https://doi.org/10.1128/AAC.00569-08.Full Text Link to Item
-
Baker-Smith, Carissa M., Daniel K. Benjamin, Henry G. Grabowski, Elizabeth D. Reid, Barry Mangum, John V. Goldsmith, M Dianne Murphy, et al. “The economic returns of pediatric clinical trials of antihypertensive drugs.” Am Heart J 156, no. 4 (October 2008): 682–88. https://doi.org/10.1016/j.ahj.2008.05.001.Full Text Link to Item
-
McDowell, Roddy, Jennifer S. Li, Daniel Kelly Benjamin, Claire Morgan, Alison Becker, Priya S. Kishnani, and Ronald J. Kanter. “Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease.” Genet Med 10, no. 10 (October 2008): 758–62. https://doi.org/10.1097/GIM.0b013e318183722f.Full Text Link to Item
-
Li, J. S., C. M. Baker-Smith, P. B. Smith, V. Hasselblad, M. D. Murphy, R. M. Califf, and D. K. Benjamin. “Racial differences in blood pressure response to angiotensin-converting enzyme inhibitors in children: a meta-analysis.” Clin Pharmacol Ther 84, no. 3 (September 2008): 315–19. https://doi.org/10.1038/clpt.2008.113.Full Text Link to Item
-
Smith, P Brian, Daniel K. Benjamin, M Dianne Murphy, Rosemary Johann-Liang, Solomon Iyasu, Barbara Gould, Robert M. Califf, Jennifer S. Li, and William Rodriguez. “Safety monitoring of drugs receiving pediatric marketing exclusivity.” Pediatrics 122, no. 3 (September 2008): e628–33. https://doi.org/10.1542/peds.2008-0585.Full Text Link to Item
-
Wratney, Angela T., Daniel Kelly Benjamin, Anthony D. Slonim, James He, Donna S. Hamel, and Ira M. Cheifetz. “The endotracheal tube air leak test does not predict extubation outcome in critically ill pediatric patients.” Pediatr Crit Care Med 9, no. 5 (September 2008): 490–96. https://doi.org/10.1097/PCC.0b013e3181849901.Full Text Link to Item
-
Smith, P Brian, Daniel K. Benjamin, C Michael Cotten, Eric Schultz, Rose Guo, Lisa Nowell, Mary Laura Smithwick, and Courtney D. Thornburg. “Is an increased dwell time of a peripherally inserted catheter associated with an increased risk of bloodstream infection in infants?” Infect Control Hosp Epidemiol 29, no. 8 (August 2008): 749–53. https://doi.org/10.1086/589905.Full Text Link to Item
-
Smith, P Brian, Harmony P. Garges, C Michael Cotton, Thomas J. Walsh, Reese H. Clark, and Daniel K. Benjamin. “Meningitis in preterm neonates: importance of cerebrospinal fluid parameters.” Am J Perinatol 25, no. 7 (August 2008): 421–26. https://doi.org/10.1055/s-0028-1083839.Full Text Link to Item
-
Baddley, J. W., D. K. Benjamin, M. Patel, J. Miró, E. Athan, B. Barsic, E. Bouza, et al. “Candida infective endocarditis.” Eur J Clin Microbiol Infect Dis 27, no. 7 (July 2008): 519–29. https://doi.org/10.1007/s10096-008-0466-x.Full Text Link to Item
-
Yanni, Souzan B., Pieter P. Annaert, Patrick Augustijns, Arlene Bridges, Yan Gao, Daniel K. Benjamin, and Dhiren R. Thakker. “Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes.” Drug Metab Dispos 36, no. 6 (June 2008): 1119–25. https://doi.org/10.1124/dmd.107.019646.Full Text Link to Item
-
Grussemeyer, C. A., J. Y. Friedman, J. R. Spalding, D. K. Benjamin, C. Moran, and S. D. Reed. “IN1 C. ALBICANS AND C. GLABRATA BLOODSTREAM INFECTIONS IN ADULTS: OUTCOMES AND ASSOCIATED COSTS.” Value in Health 11, no. 3 (May 2008): A24–A24. https://doi.org/10.1016/s1098-3015(10)70088-7.Full Text
-
Benjamin, Daniel K. “First, do no harm.” Pediatrics 121, no. 4 (April 2008): 831–32. https://doi.org/10.1542/peds.2008-0068.Full Text Link to Item
-
Benjamin, Daniel K., P Brian Smith, Pravin Jadhav, Jogarao V. Gobburu, M Dianne Murphy, Vic Hasselblad, Carissa Baker-Smith, Robert M. Califf, and Jennifer S. Li. “Pediatric antihypertensive trial failures: analysis of end points and dose range.” Hypertension 51, no. 4 (April 2008): 834–40. https://doi.org/10.1161/HYPERTENSIONAHA.107.108886.Full Text Link to Item
-
Koeberl, Dwight D., Carlos Pinto, Baodong Sun, Songtao Li, Daniel M. Kozink, Daniel K. Benjamin, Amanda K. Demaster, et al. “AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.” Mol Ther 16, no. 4 (April 2008): 665–72. https://doi.org/10.1038/mt.2008.15.Full Text Link to Item
-
Smith, P Brian, Jennifer S. Li, M Dianne Murphy, Robert M. Califf, and Daniel K. Benjamin. “Safety of placebo controls in pediatric hypertension trials.” Hypertension 51, no. 4 (April 2008): 829–33. https://doi.org/10.1161/HYPERTENSIONAHA.107.104950.Full Text Link to Item
-
Cohen-Wolkowiez, M., P. B. Smith, D. K. Benjamin, V. G. Fowler, and K. C. Wade. “Daptomycin use in infants: report of two cases with peak and trough drug concentrations.” J Perinatol 28, no. 3 (March 2008): 233–34. https://doi.org/10.1038/sj.jp.7211898.Full Text Link to Item
-
Crowley, Anna Lisa, Gail E. Peterson, Daniel K. Benjamin, Susan H. Rimmer, Cindy Todd, Christopher H. Cabell, L Barth Reller, Thomas Ryan, G Ralph Corey, and Vance G. Fowler. “Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia.” Crit Care Med 36, no. 2 (February 2008): 385–90. https://doi.org/10.1097/01.CCM.0B013E3181611F914.Full Text Link to Item
-
Hope, William W., Diana Mickiene, Vidmantas Petraitis, Ruta Petraitiene, Amy M. Kelaher, Joanna E. Hughes, Margaret P. Cotton, et al. “The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.” J Infect Dis 197, no. 1 (January 1, 2008): 163–71. https://doi.org/10.1086/524063.Full Text Link to Item
-
Thornburg, Courtney D., P Brian Smith, Mary Laura Smithwick, C Michael Cotten, and Daniel K. Benjamin. “Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters.” Thromb Res 122, no. 6 (2008): 782–85. https://doi.org/10.1016/j.thromres.2007.10.001.Full Text Link to Item
-
Wilfret, David A., Brent T. Baker, Elizabeth Palavecino, Cassandra Moran, and Daniel K. Benjamin. “Epidemiology of respiratory syncytial virus in various regions within North Carolina during multiple seasons.” N C Med J 69, no. 6 (2008): 447–52.Link to Item
-
Morpeth, Susan, David Murdoch, Christopher H. Cabell, Adolf W. Karchmer, Paul Pappas, Donald Levine, Francisco Nacinovich, et al. “Non-HACEK gram-negative bacillus endocarditis.” Ann Intern Med 147, no. 12 (December 18, 2007): 829–35. https://doi.org/10.7326/0003-4819-147-12-200712180-00002.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Daniel K. Benjamin, Vance G. Fowler, Kelly C. Wade, Barbara D. Alexander, Gordon Worley, Ricki F. Goldstein, and P Brian Smith. “Mortality and neurodevelopmental outcome after Staphylococcus aureus bacteremia in infants.” Pediatr Infect Dis J 26, no. 12 (December 2007): 1159–61. https://doi.org/10.1097/INF.0b013e31814620a6.Full Text Link to Item
-
Lenfestey, Robert W., P Brian Smith, M Anthony Moody, Reese H. Clark, C Michael Cotten, Patrick C. Seed, and Daniel K. Benjamin. “Predictive value of cerebrospinal fluid parameters in neonates with intraventricular drainage devices.” J Neurosurg 107, no. 3 Suppl (September 2007): 209–12. https://doi.org/10.3171/PED-07/09/209.Full Text Link to Item
-
Smith, P Brian, Daniel K. Benjamin, Barbara D. Alexander, Melissa D. Johnson, Malcolm A. Finkelman, and William J. Steinbach. “Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.” Clin Vaccine Immunol 14, no. 7 (July 2007): 924–25. https://doi.org/10.1128/CVI.00025-07.Full Text Link to Item
-
Santos, Roberto P., Pablo J. Sánchez, Asuncion Mejias, Daniel K. Benjamin, Thomas J. Walsh, Sanjay Patel, and Hasan S. Jafri. “Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.” Pediatr Infect Dis J 26, no. 4 (April 2007): 364–66. https://doi.org/10.1097/01.inf.0000258698.98370.89.Full Text Link to Item
-
Smith, P Brian, Juliette Morgan, J Daniel K. Benjamin, Scott K. Fridkin, Laurie Thomson Sanza, Lee H. Harrison, Andre N. Sofair, Sharon Huie-White, and Daniel K. Benjamin. “Excess costs of hospital care associated with neonatal candidemia.” Pediatr Infect Dis J 26, no. 3 (March 2007): 197–200. https://doi.org/10.1097/01.inf.0000253973.89097.c0.Full Text Link to Item
-
Li, Jennifer S., Eric L. Eisenstein, Henry G. Grabowski, Elizabeth D. Reid, Barry Mangum, Kevin A. Schulman, John V. Goldsmith, M Dianne Murphy, Robert M. Califf, and Daniel K. Benjamin. “Economic return of clinical trials performed under the pediatric exclusivity program.” Jama 297, no. 5 (February 7, 2007): 480–88. https://doi.org/10.1001/jama.297.5.480.Full Text Open Access Copy Link to Item
-
Cohen-Wolkowiez, M., P. B. Smith, B. Mangum, W. J. Steinbach, B. D. Alexander, C. M. Cotten, R. H. Clark, T. J. Walsh, and D. K. Benjamin. “Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures.” J Perinatol 27, no. 2 (February 2007): 97–100. https://doi.org/10.1038/sj.jp.7211628.Full Text Link to Item
-
Smith, P. B., W. J. Steinbach, C. M. Cotten, W. A. Schell, J. R. Perfect, T. J. Walsh, and D. K. Benjamin. “Caspofungin for the treatment of azole resistant candidemia in a premature infant.” J Perinatol 27, no. 2 (February 2007): 127–29. https://doi.org/10.1038/sj.jp.7211637.Full Text Link to Item
-
Stryjewski, Martin E., Lynda A. Szczech, Daniel K. Benjamin, Jula K. Inrig, Zeina A. Kanafani, John J. Engemann, Vivian H. Chu, et al. “Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.” Clin Infect Dis 44, no. 2 (January 15, 2007): 190–96. https://doi.org/10.1086/510386.Full Text Link to Item
-
Benjamin, Daniel K., and Barbara J. Stoll. “Infection in late preterm infants.” Clin Perinatol 33, no. 4 (December 2006): 871–82. https://doi.org/10.1016/j.clp.2006.09.005.Full Text Link to Item
-
Sun, Baodong, Haoyue Zhang, Daniel K. Benjamin, Talmage Brown, Andrew Bird, Sarah P. Young, Alison McVie-Wylie, Y. -. T. Chen, and Dwight D. Koeberl. “Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II.” Mol Ther 14, no. 6 (December 2006): 822–30. https://doi.org/10.1016/j.ymthe.2006.08.001.Full Text Link to Item
-
Anaissie, Elias J., Brahm H. Segal, John R. Graybill, Carola Arndt, John R. Perfect, Michael Kleinberg, Peter Pappas, et al. “Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.” Clin Infect Dis 43, no. 8 (October 15, 2006): 1031–39. https://doi.org/10.1086/509116.Full Text Link to Item
-
Benjamin, Daniel K., Philip Brian Smith, M Dianne Murphy, Rosemary Roberts, Lisa Mathis, Debbie Avant, Robert M. Califf, and Jennifer S. Li. “Peer-reviewed publication of clinical trials completed for pediatric exclusivity.” Jama 296, no. 10 (September 13, 2006): 1266–73. https://doi.org/10.1001/jama.296.10.1266.Full Text Link to Item
-
Koeberl, D. D., B. D. Sun, T. V. Damodaran, T. Brown, D. S. Millington, D. K. Benjamin, A. Bird, et al. “Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.” Gene Ther 13, no. 17 (September 2006): 1281–89. https://doi.org/10.1038/sj.gt.3302774.Full Text Link to Item
-
Ward, Robert M., William E. Benitz, Daniel K. Benjamin, Lillian Blackmon, George P. Giacoia, Mark Hudak, Tamar Lasky, William Rodriguez, and Arzu Selen. “Criteria supporting the study of drugs in the newborn.” Clin Ther 28, no. 9 (September 2006): 1385–98. https://doi.org/10.1016/j.clinthera.2006.09.007.Full Text Link to Item
-
Cohen-Wolkowiez, Michael, Daniel K. Benjamin, William J. Steinbach, and P Brian Smith. “Anidulafungin: a new echinocandin for the treatment of fungal infections.” Drugs Today (Barc) 42, no. 8 (August 2006): 533–44. https://doi.org/10.1358/dot.2006.42.8.996569.Full Text Link to Item
-
Cotten, C Michael, Scott McDonald, Barbara Stoll, Ronald N. Goldberg, Kenneth Poole, Daniel K. Benjamin, and Daniel K. National Institute for Child Health and Human Development Neonatal Research Network. “The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.” Pediatrics 118, no. 2 (August 2006): 717–22. https://doi.org/10.1542/peds.2005-2677.Full Text Link to Item
-
Menon, Sharad, Katherine Y. Berezny, Rakhi Kilaru, Daniel K. Benjamin, Joseph D. Kay, Lydie Hazan, Ronald Portman, et al. “Racial differences are seen in blood pressure response to fosinopril in hypertensive children.” Am Heart J 152, no. 2 (August 2006): 394–99. https://doi.org/10.1016/j.ahj.2005.12.025.Full Text Link to Item
-
Nageswaran, Savithri, Charles R. Woods, Daniel K. Benjamin, Laurence B. Givner, and Avinash K. Shetty. “Orbital cellulitis in children.” Pediatr Infect Dis J 25, no. 8 (August 2006): 695–99. https://doi.org/10.1097/01.inf.0000227820.36036.f1.Full Text Link to Item
-
Brooks, Richard, Christopher W. Woods, Daniel K. Benjamin, and Nancy E. Rosenstein. “Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.” Clin Infect Dis 43, no. 1 (July 1, 2006): 49–54. https://doi.org/10.1086/504804.Full Text Link to Item
-
Steinbach, William J., Robert A. Cramer, B Zachary Perfect, Yohannes G. Asfaw, Theodor C. Sauer, Laura K. Najvar, William R. Kirkpatrick, et al. “Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus.” Eukaryot Cell 5, no. 7 (July 2006): 1091–1103. https://doi.org/10.1128/EC.00139-06.Full Text Link to Item
-
Benjamin, D. K., R. Schelonka, R. White, H. P. Holley, E. Bifano, J. Cummings, K. Adcock, et al. “A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin.” J Perinatol 26, no. 5 (May 2006): 290–95. https://doi.org/10.1038/sj.jp.7211496.Full Text Link to Item
-
Garges, Harmony P., M Anthony Moody, C Michael Cotten, P Brian Smith, Kenneth F. Tiffany, Robert Lenfestey, Jennifer S. Li, Vance G. Fowler, and Daniel K. Benjamin. “Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?” Pediatrics 117, no. 4 (April 2006): 1094–1100. https://doi.org/10.1542/peds.2005-1132.Full Text Link to Item
-
Benjamin, Daniel K., Timothy Driscoll, Nita L. Seibel, Corina E. Gonzalez, Maureen M. Roden, Rahki Kilaru, Kay Clark, James A. Dowell, Jennifer Schranz, and Thomas J. Walsh. “Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.” Antimicrob Agents Chemother 50, no. 2 (February 2006): 632–38. https://doi.org/10.1128/AAC.50.2.632-638.2006.Full Text Link to Item
-
Smith, P. B., C. M. Cotten, H. P. Garges, K. F. Tiffany, R. W. Lenfestey, M. A. Moody, J. S. Li, and D. K. Benjamin. “A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis.” J Perinatol 26, no. 2 (February 2006): 111–14. https://doi.org/10.1038/sj.jp.7211438.Full Text Link to Item
-
Benjamin, Daniel K., Barbara J. Stoll, Avory A. Fanaroff, Scott A. McDonald, William Oh, Rosemary D. Higgins, Shahnaz Duara, et al. “Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.” Pediatrics 117, no. 1 (January 2006): 84–92. https://doi.org/10.1542/peds.2004-2292.Full Text Link to Item
-
Freedman, Josh, Ulrich Guller, Daniel Kelly Benjamin, Laurence D. Higgins, Deng Pan, Chad Cook, and Ricardo Pietrobon. “National trends in health care utilization and racial and socioeconomic disparities in pediatric pyogenic arthritis.” J Pediatr Orthop 26, no. 6 (2006): 709–15. https://doi.org/10.1097/01.bpo.0000229973.78565.02.Full Text Link to Item
-
Schelonka, Robert L., Brenda Katz, Ken B. Waites, and Daniel K. Benjamin. “Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques.” Pediatr Infect Dis J 24, no. 12 (December 2005): 1033–39. https://doi.org/10.1097/01.inf.0000190632.31565.83.Full Text Link to Item
-
Steinbach, William J., and Daniel K. Benjamin. “New antifungal agents under development in children and neonates.” Curr Opin Infect Dis 18, no. 6 (December 2005): 484–89. https://doi.org/10.1097/01.qco.0000185986.64759.9a.Full Text Link to Item
-
Steinbach, William J., John R. Perfect, Christopher H. Cabell, Vance G. Fowler, G Ralph Corey, Jennifer S. Li, Aimee K. Zaas, and Daniel K. Benjamin. “A meta-analysis of medical versus surgical therapy for Candida endocarditis.” J Infect 51, no. 3 (October 2005): 230–47. https://doi.org/10.1016/j.jinf.2004.10.016.Full Text Link to Item
-
Smith, P Brian, William J. Steinbach, and Daniel K. Benjamin. “Neonatal candidiasis.” Infect Dis Clin North Am 19, no. 3 (September 2005): 603–15. https://doi.org/10.1016/j.idc.2005.05.007.Full Text Link to Item
-
Nielsen, Kirsten, Gary M. Cox, Anastasia P. Litvintseva, Eleftherios Mylonakis, Stephanie D. Malliaris, Daniel K. Benjamin, Steven S. Giles, et al. “Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.” Infect Immun 73, no. 8 (August 2005): 4922–33. https://doi.org/10.1128/IAI.73.8.4922-4933.2005.Full Text Link to Item
-
Tiffany, Kenneth F., Phillip B. Smith, and Daniel K. Benjamin. “Neonatal candidiasis: prophylaxis and treatment.” Expert Opin Pharmacother 6, no. 10 (August 2005): 1647–55. https://doi.org/10.1517/14656566.6.10.1647.Full Text Link to Item
-
Zaoutis, Theoklis E., Daniel K. Benjamin, and William J. Steinbach. “Antifungal treatment in pediatric patients.” Drug Resist Updat 8, no. 4 (August 2005): 235–45. https://doi.org/10.1016/j.drup.2005.06.005.Full Text Link to Item
-
Brian Smith, P., William J. Steinbach, and Daniel K. Benjamin. “Invasive Candida infections in the neonate.” Drug Resist Updat 8, no. 3 (June 2005): 147–62. https://doi.org/10.1016/j.drup.2005.04.007.Full Text Link to Item
-
El-Ahdab, Fadi, Daniel Kelly Benjamin, Andrew Wang, Christopher H. Cabell, Vivian H. Chu, Martin E. Stryjewski, G Ralph Corey, Daniel J. Sexton, L Barth Reller, and Vance G. Fowler. “Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia.” Am J Med 118, no. 3 (March 2005): 225–29. https://doi.org/10.1016/j.amjmed.2004.12.017.Full Text Link to Item
-
Fowler, Vance G., Anita Justice, Catrin Moore, Daniel K. Benjamin, Christopher W. Woods, Steven Campbell, L Barth Reller, G Ralph Corey, Nicholas P. J. Day, and Sharon J. Peacock. “Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia.” Clin Infect Dis 40, no. 5 (March 1, 2005): 695–703. https://doi.org/10.1086/427806.Full Text Link to Item
-
Tiffany, K. F., D. K. Benjamin, P. Palasanthiran, K. O’Donnell, and L. T. Gutman. “Improved neurodevelopmental outcomes following long-term high-dose oral acyclovir therapy in infants with central nervous system and disseminated herpes simplex disease.” J Perinatol 25, no. 3 (March 2005): 156–61. https://doi.org/10.1038/sj.jp.7211247.Full Text Link to Item
-
Steinbach, William J., Nina Singh, Jackie L. Miller, Daniel K. Benjamin, Wiley A. Schell, Joseph Heitman, and John R. Perfect. “In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.” Antimicrob Agents Chemother 48, no. 12 (December 2004): 4922–25. https://doi.org/10.1128/AAC.48.12.4922-4925.2004.Full Text Link to Item
-
Benjamin, Daniel K., Steven Hirschfeld, Coleen K. Cunningham, and Ross E. McKinney. “Growth as a part of the composite endpoint in paediatric antiretroviral clinical trials.” J Antimicrob Chemother 54, no. 4 (October 2004): 701–3. https://doi.org/10.1093/jac/dkh410.Full Text Link to Item
-
Steinbach, William J., Daniel K. Benjamin, Scott A. Trasi, Jackie L. Miller, Wiley A. Schell, Aimee K. Zaas, W Michael Foster, and John R. Perfect. “Value of an inhalational model of invasive aspergillosis.” Med Mycol 42, no. 5 (October 2004): 417–25. https://doi.org/10.1080/13693780410001712034.Full Text Link to Item
-
Steinbach, William J., John R. Perfect, Wiley A. Schell, Thomas J. Walsh, and Daniel K. Benjamin. “In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.” Antimicrob Agents Chemother 48, no. 9 (September 2004): 3217–25. https://doi.org/10.1128/AAC.48.9.3217-3225.2004.Full Text Link to Item
-
Chu, V. H., C. H. Cabell, D. K. Benjamin, E. F. Kuniholm, V. G. Fowler, J. Engemann, D. J. Sexton, G. R. Corey, and A. Wang. “Infective endocarditis: Should diabetic patients be treated more aggressively? Response.” Circulation 110, no. 7 (August 17, 2004): E72–E72.Link to Item
-
Dixon, Terry C., William J. Steinbach, Daniel K. Benjamin, Larry W. Williams, and Laurie A. Myers. “Disseminated Candida tropicalis in a patient with chronic mucocutaneous candidiasis.” South Med J 97, no. 8 (August 2004): 788–90. https://doi.org/10.1097/00007611-200408000-00024.Full Text Link to Item
-
Steinbach, William J., Daniel K. Benjamin, Dimitrios P. Kontoyiannis, John R. Perfect, Irja Lutsar, Kieren A. Marr, Michail S. Lionakis, Harrys A. Torres, Hasan Jafri, and Thomas J. Walsh. “Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.” Clin Infect Dis 39, no. 2 (July 15, 2004): 192–98. https://doi.org/10.1086/421950.Full Text Link to Item
-
Clark, Reese, Richard Powers, Robert White, Barry Bloom, Pablo Sanchez, and Daniel K. Benjamin. “Prevention and treatment of nosocomial sepsis in the NICU.” J Perinatol 24, no. 7 (July 2004): 446–53. https://doi.org/10.1038/sj.jp.7211125.Full Text Link to Item
-
Clark, Reese, Richard Powers, Robert White, Barry Bloom, Pablo Sanchez, and Daniel K. Benjamin. “Nosocomial infection in the NICU: a medical complication or unavoidable problem?” J Perinatol 24, no. 6 (June 2004): 382–88. https://doi.org/10.1038/sj.jp.7211120.Full Text Link to Item
-
Cunnion, Kenji M., Daniel K. Benjamin, C Garren Hester, and Michael M. Frank. “Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.” J Lab Clin Med 143, no. 6 (June 2004): 358–65. https://doi.org/10.1016/j.lab.2004.03.005.Full Text Link to Item
-
Chu, Vivian H., Christopher H. Cabell, Daniel K. Benjamin, Erin F. Kuniholm, Vance G. Fowler, John Engemann, Daniel J. Sexton, G Ralph Corey, and Andrew Wang. “Early predictors of in-hospital death in infective endocarditis.” Circulation 109, no. 14 (April 13, 2004): 1745–49. https://doi.org/10.1161/01.CIR.0000124719.61827.7F.Full Text Link to Item
-
Weintrob, Amy C., John D. Hamilton, Christine Hahn, Donna Klinzman, Gustav Moyo, Dietmar Zdunek, Georg Hess, Daniel K. Benjamin, and Jack T. Stapleton. “Active or prior GB virus C infection does not protect against vertical transmission of HIV in coinfected women from Tanzania.” Clin Infect Dis 38, no. 6 (March 15, 2004): e46–48. https://doi.org/10.1086/382079.Full Text Link to Item
-
Benjamin, Daniel K., Elizabeth DeLong, Charles M. Cotten, Harmony P. Garges, William J. Steinbach, and Reese H. Clark. “Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia.” J Perinatol 24, no. 3 (March 2004): 175–80. https://doi.org/10.1038/sj.jp.7211068.Full Text Link to Item
-
Benjamin, Daniel K., Elizabeth R. DeLong, Charles M. Cotten, Harmony P. Garges, and Reese H. Clark. “Postconception age and other risk factors associated with mortality following Gram-negative rod bacteremia.” J Perinatol 24, no. 3 (March 2004): 169–74. https://doi.org/10.1038/sj.jp.7211047.Full Text Link to Item
-
Miller, J. L., W. A. Schell, E. A. Wills, D. L. Toffaletti, M. Boyce, D. K. Benjamin, J. Bartroli, and J. R. Perfect. “In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.” Antimicrob Agents Chemother 48, no. 2 (February 2004): 384–87. https://doi.org/10.1128/AAC.48.2.384-387.2004.Full Text Link to Item
-
Drew, Richard H., Elizabeth Dodds Ashley, Daniel K. Benjamin, R. Duane Davis, Scott M. Palmer, and John R. Perfect. “Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.” Transplantation 77, no. 2 (January 27, 2004): 232–37. https://doi.org/10.1097/01.TP.0000101516.08327.A9.Full Text Link to Item
-
Benjamin, D. K., W. C. Miller, R. W. Ryder, D. J. Weber, E. Walter, and R. E. McKinney. “Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings.” Aids Patient Care Stds 18, no. 1 (January 2004): 35–43. https://doi.org/10.1089/108729104322740901.Full Text Link to Item
-
Benjamin, Daniel K., Elizabeth DeLong, and William J. Steinbach. “Latent class analysis: an illustrative application for education in the assessment of resident otoscopic skills.” Ambul Pediatr 4, no. 1 (2004): 13–17. https://doi.org/10.1367/1539-4409(2004)004<0013:lcaaia>2.0.co;2.Full Text Link to Item
-
Benjamin, Daniel K., Jose M. Miro, Bruno Hoen, William J. Steinbach, Vance G. Fowler, Lars Olaison, Gilbert Habib, et al. “Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD).” Scand J Infect Dis 36, no. 6–7 (2004): 453–55. https://doi.org/10.1080/00365540410020703.Full Text Link to Item
-
Benjamin, Daniel K., Wiliam C. Miller, Robert W. Ryder, David J. Weber, Emmanuel Walter, and Ross E. McKinney. “A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV.” Aids 17, no. 16 (November 7, 2003): 2331–36. https://doi.org/10.1097/00002030-200311070-00007.Full Text Link to Item
-
Benjamin, Daniel K., Harmony Garges, and William J. Steinbach. “Candida bloodstream infection in neonates.” Semin Perinatol 27, no. 5 (October 2003): 375–83. https://doi.org/10.1016/s0146-0005(03)00061-2.Full Text Link to Item
-
Weintrob, Amy C., Julieta Giner, Prema Menezes, Ericka Patrick, Daniel Kelly Benjamin, Jeffrey Lennox, Christopher D. Pilcher, Joseph J. Eron, and Charles B. Hicks. “Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.” Arch Intern Med 163, no. 17 (September 22, 2003): 2097–2100. https://doi.org/10.1001/archinte.163.17.2097.Full Text Link to Item
-
Benjamin, Daniel K., Charles Poole, William J. Steinbach, Judith L. Rowen, and Thomas J. Walsh. “Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques.” Pediatrics 112, no. 3 Pt 1 (September 2003): 634–40. https://doi.org/10.1542/peds.112.3.634.Full Text Link to Item
-
Benjamin, Daniel K., Elizabeth R. DeLong, William J. Steinbach, Charles M. Cotton, Thomas J. Walsh, and Reese H. Clark. “Empirical therapy for neonatal candidemia in very low birth weight infants.” Pediatrics 112, no. 3 Pt 1 (September 2003): 543–47. https://doi.org/10.1542/peds.112.3.543.Full Text Link to Item
-
Koeberl, Dwight D., Sarah P. Young, Niels S. Gregersen, Jerry Vockley, Wendy E. Smith, Daniel Kelly Benjamin, Yan An, et al. “Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening.” Pediatr Res 54, no. 2 (August 2003): 219–23. https://doi.org/10.1203/01.PDR.0000074972.36356.89.Full Text Link to Item
-
Beaty, R. M., M. Jackson, D. Peterson, A. Bird, T. Brown, D. K. Benjamin, T. Juopperi, et al. “Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors.” Gene Ther 9, no. 15 (August 2002): 1015–22. https://doi.org/10.1038/sj.gt.3301728.Full Text Link to Item
-
Fisher, Randall G., and Daniel K. Benjamin. “Facial cellulitis in childhood: a changing spectrum.” South Med J 95, no. 7 (July 2002): 672–74.Link to Item
-
Steinbach, William J., Theodore C. Sectish, Daniel K. Benjamin, Kay W. Chang, and Anna H. Messner. “Pediatric residents' clinical diagnostic accuracy of otitis media.” Pediatrics 109, no. 6 (June 2002): 993–98. https://doi.org/10.1542/peds.109.6.993.Full Text Link to Item
-
Calland, J Forrest, Reid B. Adams, Daniel K. Benjamin, Matthew J. O’Connor, Vinay Chandrasekhara, Stephanie Guerlain, and Rayford Scott Jones. “Thirty-day postoperative death rate at an academic medical center.” Ann Surg 235, no. 5 (May 2002): 690–96. https://doi.org/10.1097/00000658-200205000-00011.Full Text Link to Item
-
Benjamin, D. K. “Integration of statistical theory and practical clinical expertise. Polymerase chain reaction testing of the HIV-exposed infant.” Minerva Pediatr 54, no. 2 (April 2002): 105–11.Link to Item
-
Dyke, C. K., D. K. Benjamin, C. L. Nelson, K. Newby, C. O’shea, W. Cantor, C. Nguyen, J. H. Alexander, M. M. Kitt, and J. E. Tcheng. “Elevated troponin following percutaneous coronary intervention predicts subsequent events: Results from the ESPRIT trial.” Journal of the American College of Cardiology 39, no. 5 (March 6, 2002): 72A-72A.Link to Item
-
Benjamin, Daniel Kelly, William C. Miller, Sherry Bayliff, Lisa Martel, Kenneth A. Alexander, and Paul Langlie Martin. “Infections diagnosed in the first year after pediatric stem cell transplantation.” Pediatr Infect Dis J 21, no. 3 (March 2002): 227–34. https://doi.org/10.1097/00006454-200203000-00013.Full Text Link to Item
-
Benjamin, D. K., W. C. Miller, S. A. Fiscus, M. Morse, M. Valentine, and R. E. McKinney. “Rational testing of the HIV-exposed infant.” Pediatrics 108, no. 1 (July 2001): E3. https://doi.org/10.1542/peds.108.1.e3.Full Text Link to Item
-
Benjamin, D. K., W. Miller, H. Garges, R. E. McKinney, M. Cotton, R. G. Fisher, and K. A. Alexander. “Bacteremia, central catheters, and neonates: when to pull the line.” Pediatrics 107, no. 6 (June 2001): 1272–76. https://doi.org/10.1542/peds.107.6.1272.Full Text Link to Item
-
Benjamin, D. K., K. Ross, R. E. McKinney, R. Auten, and R. G. Fisher. “When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.” Pediatrics 106, no. 4 (October 2000): 712–18. https://doi.org/10.1542/peds.106.4.712.Full Text Link to Item
-
Benjamin, D. K., R. G. Fisher, and R. E. McKinney. “Candidal mycetoma in the neonatal kidney.” Pediatrics 104, no. 5 Pt 1 (November 1999): 1126–29. https://doi.org/10.1542/peds.104.5.1126.Full Text Link to Item
-
-
Book Sections
-
Benjamin, D. K. “Contracting for health and safety: Risk perception and rational choice.” In Cutting Green Tape: Pollutants, Environmental Regulation and the Law, 223–50, 2018.
-
Dumitrescu, M. P., and D. K. Benjamin. “Candida Prophylaxis.” In Infectious Disease and Pharmacology: Neonatology Questions and Controversies, 63–68, 2018. https://doi.org/10.1016/B978-0-323-54391-0.00006-0.Full Text
-
Ericson, J. E., and D. K. Benjamin. “Clinical Approach to the Infected Neonate.” In Principles and Practice of Pediatric Infectious Diseases, 547-549.e1, 2018. https://doi.org/10.1016/B978-0-323-40181-4.00091-8.Full Text
-
Zimmerman, K., and D. K. Benjamin. “Necrotizing Enterocolitis.” In Principles and Practice of Pediatric Infectious Diseases, 394-397.e2, 2018. https://doi.org/10.1016/B978-0-323-40181-4.00058-X.Full Text
-
Smyth, R. L., G. Kaur, D. K. Benjamin, and M. M. Laughon. “Recruitment and Retention in Pediatric Clinical Trials: Focus on Pediatric Research Networks in the US and EU.” In Pediatric Drug Development: Concepts and Applications, 455–71, 2013. https://doi.org/10.1002/9781118312087.ch36.Full Text
-
Cotten, C. M., and D. K. Benjamin. “Necrotizing Enterocolitis.” In Principles and Practice of Pediatric Infectious Diseases: Fourth Edition, 388-391.e2, 2012. https://doi.org/10.1016/B978-1-4377-2702-9.00060-X.Full Text
-
Smith, P. B., and D. K. Benjamin. “Clinical Approach to the Infected Neonate.” In Principles and Practice of Pediatric Infectious Diseases: Fourth Edition, 536-538.e1, 2012. https://doi.org/10.1016/B978-1-4377-2702-9.00093-3.Full Text
-
Li, Jennifer S., Daniel K. Benjamin, Thomas Severin, and Ronald J. Portman. “Pediatric Antihypertensive Clinical Trials.” In Pediatric Hypertension, 575–85. Humana Press, 2011. https://doi.org/10.1007/978-1-60327-824-9_33.Full Text
-
Wade, K. C., and D. K. Benjamin. “Clinical pharmacology of anti-infective drugs.” In Infectious Diseases of the Fetus and Newborn: Expert Consult - Online and Print, 1160–1211, 2010. https://doi.org/10.1016/B978-1-4160-6400-8/00037-7.Full Text
-
-
Conference Papers
-
Ganguly, Samit, Andrea N. Edginton, Jacqueline G. Gerhart, Michael Cohen-Wolkowiez, Rachel G. Greenberg, Daniel Gonzalez, and Daniel Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee. “Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants.” In Clin Pharmacokinet, 60:1591–1604, 2021. https://doi.org/10.1007/s40262-021-01046-6.Full Text Link to Item
-
Gerhart, Jacqueline G., Kevin M. Watt, Andrea Edginton, Kelly C. Wade, Sara N. Salerno, Daniel K. Benjamin, P Brian Smith, et al. “Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants.” In Cpt Pharmacometrics Syst Pharmacol, 8:500–510, 2019. https://doi.org/10.1002/psp4.12414.Full Text Link to Item
-
Ward, Robert M., Daniel Benjamin, Jeffrey S. Barrett, Karel Allegaert, Ronald Portman, Jonathan M. Davis, and Mark A. Turner. “Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates.” In Pediatr Res, 81:692–711, 2017. https://doi.org/10.1038/pr.2016.221.Full Text Link to Item
-
Watt, K., M. Cohen-Wolkowiez, D. Williams, D. Bonadonna, I. Cheifetz, D. K. Benjamin, and K. L. Brouwer. “ANTIFUNGAL EXTRACTION BY THE EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) CIRCUIT EX VIVO.” In Clinical Pharmacology & Therapeutics, 97:S16–S16. WILEY-BLACKWELL, 2015.Link to Item
-
Yanni, Souzan B., Philip B. Smith, Daniel K. Benjamin, Patrick Augustijns, Dhiren R. Thakker, and Pieter Annaert. “Age-Dependent Disposition of Micafungin in Humans: Effect of Serum Protein Binding.” In Drug Metabolism Reviews, 42:55–56. TAYLOR & FRANCIS INC, 2010.Link to Item
-
Baker-Smith, Carissa M., Daniel K. Benjamin, Dianne Murphy, Eric L. Eisenstein, and Jennifer S. Li. “The economic return of performing pediatric anti-hypertensive drug clinical trials.” In Circulation, 116:822–822. LIPPINCOTT WILLIAMS & WILKINS, 2007.Link to Item
-
Li, Jennifer S., P Brian Smith, M Dianne Murphy, Robert M. Califf, and Daniel K. Benjamin. “Racial differences in blood pressure response to angiotensin converting enzyme inhibitors in children: An analysis of 6 pediatric hypertension trials.” In Circulation, 116:614–614. LIPPINCOTT WILLIAMS & WILKINS, 2007.Link to Item
-
Benjamin, D. K., E. DeLong, C. M. Cotten, H. P. Garges, W. J. Steinbach, and R. H. Clark. “Mortality following blood culture in premature infants: Increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia.” In Pediatric Research, 55:403A-403A. INT PEDIATRIC RESEARCH FOUNDATION, INC, 2004.Link to Item
-
Tiffany, K. F., D. K. Benjamin, K. J. O’Donnell, and L. T. Gutman. “Improved neuro-developmental outcomes following long-term suppressive oral acyclovir in infants with disseminated/encephalitic herpes simplex disease.” In Pediatric Research, 55:397A-397A. INT PEDIATRIC RESEARCH FOUNDATION, INC, 2004.Link to Item
-
Benjamin, D. K., E. R. Delong, W. J. Steinbach, C. M. Cotten, T. J. Walsh, and R. H. Clark. “Empirical therapy for neonatal candidemia: Evaluation of 21,233 blood cultures.” In Pediatric Research, 53:396A-396A. INT PEDIATRIC RESEARCH FOUNDATION, INC, 2003.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.